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6 
Introduction 
 
Freely circulating and collectively used testosterone is dynamite for the 
heterosexual regime.   1
 
My biopolitical options are as follows: either I declare myself to be a transsexual, 
or I declare myself to be drugged and psychotic.   2
 
 
Last winter, I decided to start actively pursuing what is known as chest masculinization 
or “top surgery.” I called a plastic surgeon in New York to request a consultation. While we were 
trying to settle on a date, the secretary inquired of me: 
“...and you’ve been on testosterone for at least one year, right?”  
 
“No, do I have to be to schedule a consult?”  
 
“Oh yes, the doctor won’t see you for a consultation unless you’ve been on testosterone for one 
year and have two letters of recommendation, one from your hormone provider, and one from a 
mental health professional.” 
 
I tried to find another surgeon in New York that do the procedure without me fulfilling those 
criteria to no avail--the ones that would didn’t accept my insurance, so I would have had to pay 
between $7,000-$10,000 out of pocket if I wanted to see them. I requested some forms from my 
insurance provider to find out who else was in-network when I realized that my policy said the 
same thing: one year of hormone therapy and two letters of recommendation to get top surgery 
covered as a treatment for gender dysphoria.  
I thought, ​What the hell, I might as well start taking T (testosterone) if that’s the only way 
I can get top surgery.​ During a visit with my primary care physician to start hormone therapy, I 
1 ​Paul B. Preciado. ​Testo Junkie: Sex, Drugs, and Biopolitics in the Pharmacopornographic Era​. Feminist Press. 
2013. 230. 
2 ​Paul B. Preciado. ​Testo Junkie: Sex, Drugs, and Biopolitics in the Pharmacopornographic Era​. Feminist Press. 
2013. 256. 
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realized as I was explaining what I wanted to her that she had never had a trans patient before. 
She had no answers to the questions that I asked about the effects of testosterone, how much it 
would cost, what options I had in terms of the form the medication would come in. I felt 
awkward sitting on the padded table explaining myself to her while she looked at me blankly. 
When I left with no prescription for testosterone, she referred me to a plastic surgeon who she 
said could perform top surgery. When I called the office phone, they said, “No, sorry, the doctor 
doesn’t do that kind of surgery.” 
Fast forward a few months, and I’ve finally gotten a prescription for testosterone gel from 
a trans-friendly provider at a nearby reproductive health clinic. When I go to pick up the 
prescription, they tell me it will cost a few hundred dollars because my insurance has not covered 
it. After leaving the pharmacy without my prescription, I called my insurance provider and was 
on hold for about an hour until someone finally said they had not given a prior-authorization for 
the prescription. We exchanged calls more than 30 times over the next two months, and finally, I 
was able to pick up my prescription. 
A year after being on testosterone, I finally made an appointment with a therapist in order 
to get a recommendation for my top surgery. Despite this therapist being trans himself, he 
required that I come in three times to talk about my relationship to my gender and my reasons for 
wanting surgery. As he was asking me about how long I’ve wanted to get top surgery during one 
of our 50-minute long sessions, I couldn’t help but wanting to talk about some other personal 
issues causing me stress. I was frustrated by this, particularly because I have been “living as” 
trans for well over four years now. 
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As I went through this process, I assembled the research that would become this project. 
Many of the materials that I encountered while researching were incredibly painful to look at, 
most notably arguments about transition regret and trans-exclusionary radical feminists. It was 
very important to me to continue writing this project, and helped me dispel the anxieties I was 
having about my choices to pursue hormone therapy and top surgery and be more sure of my 
decisions. 
On March 13, 2019, I finally was able to get top surgery. My experience, although it was 
extremely frustrating and time-consuming, pales in comparison to what many other trans people 
go through in order to access the embodiment that they are seeking. Many trans people are not 
able to pursue procedures like top surgery precisely because it is so difficult to access. (Unless, 
of course, you pay out-of-pocket). 
In writing this project, I wanted to speak to the reasons why materializing our desired 
embodiments is so inaccessible and difficult for many trans people. I offer an analysis of the 
relationship that trans people have to transition-related healthcare in the contemporary United 
States that is grounded in historical context, drawing both from the medical profession itself and 
the trans people who have interacted with it, placing a particular emphasis on centralizing the 
voices of trans people most affected by interlocking systems of oppression on the basis of their 
race, class, and sexuality. Chapter 1 focuses on the years between 1950-1979, during which 
gender variance was medicalized within medical and popular discourse as a pathology known as 
‘transsexualism’ with a set treatment that consisted of counseling, hormone therapy, and surgery. 
I argue that endocrinologist Harry Benjamin and famous trans woman Christine Jorgensen were 
two figures central to constructing transsexual through invoking notions whiteness, 
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heterosexuality, and middle-class sensibility to render it intelligible. Chapter 2 deals with the 
standardization and professionalization of the treatment for this pathology that started with the 
closure of university-based gender identity clinics in 1979. I argue that the gatekeeping model of 
trans healthcare is aimed at controlling, disciplining, and regulating the expression of gender 
variance, thereby restricting access to those who can meet strict diagnostic criteria. Chapter 3 
argues that privatization of these treatments, which started in the 1980s, and the simultaneous 
exclusion from coverage by most major health insurance plans separated the treatment from the 
pathology, and constructing medical care as a luxury that only few can afford to access. The 
conclusion seeks to imagine an alternative, in which gender variance is demedicalized and 
gender affirming care is freely accessible to all those that seek it. 
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Chapter 1 
 
Inventing the Transsexual Phenomenon: Medicalizing Gender Variance in Mid-Twentieth 
Century U.S. Medical Discourse and Popular Culture 
 
Being a true physician, Benjamin treated all these patients as people and 
by respectfully listening to each individual voice, he learned from them 
what gender dysphoria was about. These early patients must be lauded for 
their courage in seeking a description of and a solution to a phenomenon 
that had as yet no description and no solution. They discovered a 
physician who was willing to try to treat their unusual condition in a way 
that had never been attempted before.  3
 
 
Personally, he only did girls he thought would pass. He only did white 
girls. Would help those girls. So taller girls like myself had to find other 
places. The black girls had to go to other places.  4
  
 
 
 
During the later half of the twentieth century (1948-1979), gender variance was 
medicalized within medical discourse as a diagnosable condition known as ‘transsexualism,’ 
which had one legitimate treatment path. Medical professionals, such as Harry Benjamin, laid 
claims to expert knowledge about the ‘transsexual’ condition and dominion over its 
management. At the same time, stories and images of trans people emerged and circulated in 
newspapers and books, marking the first time that many people in the U.S. would hear about 
‘transsexuals.’. How were the ‘symptoms’ of this condition constructed within medical 
discourse? What were the goals of treatment? What was at stake in medicalizing gender variance 
3 ​Leah Cahan Schaefer and Connie Christine Wheeler, "Harry Benjamin's first ten cases (1938-1953): A clinical 
historical note." ​Archives of Sexual Behavior Vol. 24, no. 1​, 73-93. March 1995. 
https://doi.org/10.1007/BF01541990.  
4 ​Miss Major Griffin-Gracy interviewed by AJ Lewis, ​New York City Trans Oral History Project​. Interview Date 
December 16, 2017. Transcript #054. 
https://s3.amazonaws.com/oral-history/transcripts/NYC+TOHP+Transcript+054+Miss+Major+Griffin-Gracy.pdf. 
Accessed April 30, 2019. 
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as ‘transsexualism’? How did its construction in media foreclose possibilities for certain bodies 
to be intelligible as ‘transsexuals’ and access this world of meaning?  
 
Biopower, Problematization, and Medicalization 
In order to ground this chapter, I open with Michel Foucault’s concept of medicalization, 
which “...describes a process by which nonmedical problems become defined and treated as 
medical problems, usually in terms of illnesses or disorders.”  The concept is typically applied 5
when to critically analyze a phenomenon which someone is arguing ought not to have been 
medicalized, rather than simply stating that something has become medical. Sociologist Peter 
Conrad writes that the thrust of medicalization lies in the power of definitions: Medicalization 
consists of defining a problem in medical terms, using medical language to describe a problem, 
adopting a medical framework to understand a problem, or using a medical intervention to "treat" 
it.”  These definitions, exhibited by diagnostic criteria, symptoms, and treatment options, render 6
social and bodily phenomenon into pathologies that must be understood and managed through 
social control. 
Foucault’s concept of ‘biopower,’ the “administration of bodies and the calculated 
management of life”  is best characterized by the “power to qualify, measure, appraise, and 7
hierarchize”  on the part of social institutions like medicine. Foucault notes that the key sites of 8
medical biopower and knowledge are sex, race, and gender, which had to be subjected to 
5 Peter Conrad, “Medicalization and Social Control” in ​Annual Review of Sociology, Vol. 18,​ 209-232. Annual 
Reviews. 1992. https://www.jstor.org/stable/2083452. 209. 
6 ​Peter Conrad, “Medicalization and Social Control,” 211. 
7 ​Michel Foucault. “Right of Death and Power over Life” in ​The History of Sexuality, Volume I​. Random House. 
1978. Available online through http://home.ku.edu.tr/~mbaker/CSHS503/FoucaultHistorySex.pdf. 262. 
8 Foucault, “Right of Death and Power over Life,” 266. 
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biopower in order to maintain production relations under capitalism. He writes on sex, “Power 
delineated it, aroused it, and employed it as ​the proliferating meaning that had always to be 
taken control of again lest it escape.​”  Biopower, then, is exercised by all the institutional bodies 9
and figures that exert social control over gender variance. Its goal is to maintain and manage life, 
providing access to medical services only through the mediation and control of medical 
professionals, who monitor, scrutinize, and evaluate who is allowed to access transition-related 
care and under what conditions. 
Trans activist and attorney Dean Spade writes that the medicalization of gender variance, 
and thereby the normalization of biological sex and gender, constructs it as an visible social 
problem to be controlled and suppressed:   10
...medicine produces it [a fiction of natural gender] not through a description of 
the norm, but through a generalized account of the norms transgression by gender 
deviants. By instructing the doctor/parent/teacher to focus on the transgressive 
behavior, the diagnostic criteria for GID  establishes surveillance and regulation 11
effective for keeping both non-transsexuals and transsexuals in adherence to their 
roles.   12
 If gender variance were to be understood as a normal social phenomenon consisting of existing 
outside, in-between, and/or in opposition to binary sex and gender, the sex/gender system, 
supposedly rooted in innate biological differences between ‘men’ and ‘women,’ would be 
destabilized. By theorizing gender variance as an inherent pathology, medicalization has 
functioned to allow only those who purport to uphold this system to access transition-related 
hormonal interventions and surgery, thereby upholding the binary sex/gender system through 
maintaining that gender variants are an errant, uncontrollable, medical phenomenon. 
9 Foucault. “Right of Death and Power over Life,” 260. Emphasis added. 
10 ​Dean Spade, “Resisting Medicine, Re/modeling Gender” in ​Berkeley Women’s Law Journal, Vol. 15​, 15-27. 
http://www.deanspade.net/wp-content/uploads/2010/07/resisting.pdf. 2003. 25. 
11 Gender Identity Disorder. 
12 ​Dean Spade,“Resisting Medicine, Re/modeling Gender,” 25-26. 
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Dr. Harry Benjamin Invents the Transsexual 
Dr. Harry Benjamin (1885-1986) is often canonized  as the father of transsexualism.  13 14
His pioneering contributions single-handedly shaped much of the contemporary geography of 
trans healthcare. Benjamin was a German-American sexologist and endocrinologist, widely 
remembered for his groundbreaking work on ‘transsexualism’ between 1948-1979 in the U.S.. 
He was not the first nor the only doctor  in the U.S. to provide gender-affirming services to trans 15
people, however, his work has had a strong impact on mainstreaming and standardizing trans 
healthcare and thus deserves substantial attention. Benjamin defied the cultural and medical 
norms of his U.S. contemporaries by constructing transness as a medical condition that should be 
treated with hormones and surgery, rather than psychotherapy, thereby cracking open a new 
world in which some trans people could more readily access the embodiments they desired. At 
the same time, other possibilities were foreclosed, such as non-medical and self-determined 
conceptions of trans identity that went beyond the white, heteronormative, binary conception.  
Perhaps the defining feature of Benjamin’s work was that he advocated providing gender 
variant people, or as he called them, ‘transsexuals,’ with hormones and surgery because he 
believed that cross-gender identification had somatic causes.  Benjamin stood out amongst his 16
American contemporaries for his radical views on sexuality,  sex, and gender, expressing 17
“contempt for what he saw as prudery and hypocrisy”  in American medicine, particularly on 18
13 ​Julian Gill-Peterson. ​Histories of the Transgender Child​. University of Minnesota Press. 2018. 19. 
14 See Schaefer and Wheeler, “Harry Benjamin’s first ten cases,” and Richard Elkins, “Science, Politics, and Clinical 
Intervention: Harry Benjamin, Transsexualism, and the Problem of Heteronormativity” in ​Sexualities Vol 8, Issue 3, 
306-328. SAGE. 2005.  
15 Joanne Meyerowitz, ​How Sex Changed: A History of Transsexuality in the United States.​ Harvard University 
Press. 2002. 41-45. 
16 ​Meyerowitz, ​How Sex Changed, ​46.  
17 ​See Meyerowitz, ​How Sex Changed​, 45-46 for more. 
18 Meyerowitz, ​How Sex Changed,​ 46. 
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the part of psychologists. Benjamin writes about the prudish morality of American doctors and 
their taboo  on providing hormonal and surgical interventions to people who requested them to 19
alter their appearances: 
The forces of nature, however, know nothing of this taboo [the inviolability of 
sex/gender], and facts remain facts. Intersexes exist, in body as well as in mind. I 
have seen too many transsexual patients to let their picture and their suffering be 
obscured by uninformed albeit honest opposition. Furthermore, I felt that after 
fifty years in the practice of medicine, and in the evening of life, I need not be too 
concerned with a disapproval that touches much more on morals than on science.
 20
Many American medical professionals argued against the existence of ‘transsexualism’, arguing 
that people who experienced cross-gender identification were experiencing psychotic delusions 
that could be remedied through rigorous psychological counseling.  Take, for example, this 21
recollection from Christine Jorgensen, a trans woman, who describes an interaction with a 
psychiatrist in 1948 after explaining to him that she wanted to ‘be’ a woman: “‘I can’t guarantee 
you anything,’ he said. ‘but I’d like you to start a series of psychoanalytic treatments. About 
thirty, I would imagine.’”  Jorgensen continues, “He then explained to me that through these 22
treatments, he would try to guide me away from these ‘feminine inclinations.’” This 
psychiatrist’s reaction was typical of U.S. doctors at midcentury, who did not see hormonal or 
surgical intervention as a treatment for this condition. Indeed, historian Joanne Meyerowitz goes 
as far to say that “sex-reassignment surgery did not exist” during this period, with a few 
exceptions.   23
19 ​“Any interference with the sacrosanct stability of our sex is one of the great taboos of our time. Therefore, its 
violation is strongly resented with emotions likely to run high, even among doctors.” Harry Benjamin, ​The 
Transsexual Phenomenon. ​The Julian Press. 1966. Available online at 
http://www.mut23.de/texte/Harry%20Benjamin%20-%20The%20Transsexual%20Phenomenon.pdf. 9. 
20 ​Benjamin, ​The Transsexual Phenomenon,​ 5. 
21 ​U.S. sexologist David O. Cauldwell and sex researcher Alfred Kinsey advocated strongly against surgery as a 
‘treatment’ for transsexuality. See Meyerowitz, 44-48. 
22 ​Christine Jorgensen. ​Christine Jorgensen, A Personal Autobiography​. Bantam Books. 1967. 66. 
23 ​Meyerowitz, ​How Sex Changed​, 49. 
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Between 1938-1953, Benjamin, in his sixties, saw the first ten ‘transsexual’ patients of 
his career, who came to him when no such formal diagnosis existed.  Historian Joanne 24
Meyerowitz reminds us, “They did not need the label ‘transsexual’ or ‘transgender’ to articulate 
a request to change sex. They tried to identify their problem with whatever labels they had, and 
then they asked for help.”  For these first patients, Benjamin simultaneously functioned as an 25
endocrinologist, counselor, reference for plastic surgeons, and helped link transgender people 
with others like them.  Richard Elkins notes that this period of Benjamin’s work “...predates the 26
period of a sophisticated terminology of sex, sexuality and gender. There is no language of 
gender identity or gender dysphoria for Benjamin to draw on.”  By creating his own terms, 27
definitions, diagnostic criteria, and treatments, Benjamin assumed a massive amount of medical 
authority and took the first steps to medicalize gender variance as a condition known as 
‘transsexualism.’ Benjamin would later write in 1966, “There is a challenge as well as a 
handicap in writing a book on a subject that is not yet covered in the medical literature. 
Transsexualism is such a subject.”  Embedded within this statement is Benjamin’s 28
presupposition that ‘transsexualism’ was, in fact, a medical problem that needed to be covered in 
medical discourse, and that he was the one qualified to take the first steps to make this happen. 
 
Constructing the Symptoms 
24 ​Schaefer and Wheeler, “Harry Benjamin’s first ten cases”. 
25 ​Meyerowitz, ​How Sex Changed,​ 36. 
26 ​Schaefer and Wheeler, “Harry Benjamin’s first ten cases”. 
27 ​Richard Elkins, “Science, Politics, and Clinical Intervention: Harry Benjamin, Transsexualism and the Problem of 
Heteronormativity” in ​Sexualities​ ​Vol. 8, no. 3,​ pp. 306-328. 2005.  
28 ​Benjamin, ​The Transsexual Phenomenon,​ 4. 
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Benjamin’s construction of transsexuality as a medical problem rested on defining its 
symptoms. Although the term “transsexual” had been in use since in the U.S. since at least 1949 
when Dr. David O. Cauldwell wrote “Psychopathia Transsexualis,” Benjamin popularized the 
term “transsexual” in the early 1950s.  Many of his early patients  described experiencing 29 30
gender-confusion early in life,  distress about their bodies  characterized by a desire to be rid 31 32
of them, and an inability to function in society the way that ‘normal’ people did.  Benjamin, 33
upon hearing this information, decided that these would constitute the symptoms of ‘true’ 
transsexuality, a concept he first invoked through differentiating between the three different 
‘types’ of transsexuals, 1, 2, and 3, with 3 showing the highest “degree of sex and gender role 
confusion,” and a “much deeper emotional disturbance.” Benjamin writes, “He lives only for the 
day when his "female soul" is no longer being outraged by his male body, when he can function 
as a female - socially, legally, and sexually.”  He also considered this group to be largely 34
asexual: “...he is often asexual or masturbates on occasion, imagining himself to be female.”  ​It 35
was this group that Benjamin advocated treating with hormone therapy and surgical intervention. 
In 1949, Benjamin met his first “true”  transsexual patient, Val Barry, a 23-year-old 36
patient referred to him by sex researcher Alfred Kinsey, who met Barry while taking sex 
29 ​Susan Stryker, ​Transgender History, ​38. 
30 ​ It is important to note that 8/9 patients were male-to-female, while only one was female-to-male; all were 
socioeconomically middle-class (3 were raised in upper-class backgrounds); 9 received hormonal therapy, with 6 
undergoing genital surgery. No information about the racial/ethnic makeup of this group was provided. Schaefer and 
Wheeler, “Harry Benjamin’s first ten cases”. 
31 ​ See Benjamin, ​The Transsexual Phenomenon​, 37, and Schaefer and Wheeler, “Harry Benjamin’s first ten cases”, 
73. 
32 “The transsexual (TS) male or female is deeply unhappy as a member of the sex (or gender) to which he or she 
was assigned by the anatomical structure of the body, particularly the genitals…their sex organs, the primary (testes) 
as well as the secondary (penis and others) are disgusting deformities that must be changed by the surgeon’s knife.” 
Benjamin, ​The Transsexual Phenomenon​, 11.  
33 ​Schaefer and Wheeler, “Harry Benjamin’s first ten cases”.  
34 Benjamin, ​The Transsexual Phenomenon,​ 13-14. 
35 ​Ibid. 
36 Schaefer and Wheeler, “Harry Benjamin’s first ten cases”, 76. 
 
17 
histories in San Francisco in 1948.  Barry was desperately seeking feminizing hormones and 37
surgery to alter her body. Benjamin could provide estrogen therapy, not surgery; but he urged her 
to pursue it in Europe. Benjamin inquired  of California’s district attorney, Edmund G. Brown, 38
about the legality of castration in the state, to which Brown replied the procedure would 
constitute a violation of so-called “mayhem statues,” laws dating back to English common law in 
the middle ages which criminalized the willful disabling or destruction of the healthy tissue of 
another person.  Psychiatrist Karl Bowman and sex researcher Alfred Kinsey decided not to 39
endorse surgery for Barry, opined that surgery would not cure Barry’s psychological condition. 
Benjamin continued to assist Barry, eventually helping her to find a doctor willing to do her 
genital surgery in Sweden in 1953.   40
Interesting in regards to Barry’s story is how she is described as a ‘true transsexual’.  41
Schaefer and Wheeler write retrospectively about Barry, emphasizing that she dressed as a girl 
consistently in her early childhood, even while at school. Reviewing her institutional records, 
they write that she had a "desire from childhood to be a girl and from puberty to change 
physically”, so that she "could marry, have a house and children.”  Her desire to alter her 42
embodiment to align more with a ‘female’ body, then, seemed to stem from a pathology that took 
hold early in her life, and was also bolstered by her aspirations to become a housewife. The 
consistency of her gender expression and identification is further taken by Schaefer and Wheeler 
as evidence of symptoms characteristic of ‘transsexuals.’ Barry’s "ideas, interests, and modes of 
37 ​Schaefer and Wheeler. 
38 ​“Annoyed, Benjamin replied: ‘it is difficult to reconcile my common sense with the fact that statutes based on the 
requirements of English kings in the middle ages should still be valid…’” Meyerowitz, ​How Sex Changed, ​47.  
39 ​Stryker, ​Transgender History​, 62​. 
40 Meyerowitz, ​How Sex Changed, ​48. 
41 ​Schaefer and Wheeler, "Harry Benjamin's first ten cases”, 76. 
42 ​Schaefer and Wheeler, "Harry Benjamin's first ten cases”, 77. 
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thought were consistently feminine,” and she "denied ever having an erection (nocturnal or 
otherwise) and...ever masturbating.”  Benjamin’s idea of the true transsexual as assexual and in 43
a pure state devoid of sexuality creates a subject stripped of eroticism and desire, unable to 
experience sexuality lest they be seen as homosexual or not truly experiencing a desire to be of 
another gender. Possibilities for expressing sexuality pre-transition was threatening to the idea 
that gender preceded sexuality, a common idea in the post-war United States.   44
Benjamin’s idea of the ‘true transsexual’ was predicated on the ability and desire of the 
person to ‘pass’ as a person with binary gender. Miss Major, a black trans woman and trans 
rights activist who was born in 1942, recounted her life as a street queen during the late 1950s in 
Chicago over the course of an interview with trans historian Susan Stryker. Major obtained her 
hormones through the black market, paying an unnamed private doctor on the North side of 
Chicago $25 per shot of estrogen with money she earned through hooking.  When she moved to 45
New York City in 1960, she tried to get hormones from Benjamin to no avail. She recounted the 
experience in an interview with the New York City Trans Oral History Project: 
Girl, we tried, child, we tried. We went there and the receptionist was very polite 
and very sweet but very no. [laughs] Yeah, “he’s not seeing you”. And at the 
time, any girl that went to him, you had to go to him “done”. You couldn’t go to 
him in boy’s clothes because you were out running around during the day time. 
You had to be “done”. You had to be dressed. You had to have your shit together. 
So that means you got dressed at home, you jumped in a cab, cause you couldn’t 
go anywhere in public, we couldn’t take that chance. Directly to his office. Have 
the cab stop in front, run inside, have the cab meet you when you went to leave 
and then go home.  46
43 ​Schaefer and Wheeler, "Harry Benjamin's first ten cases”, 77. 
44 ​Michael David Franklin, “Calculating Risk History of Medicine, Transgender Oral History, and the Institutional 
Review Board” in ​Queer Twin Cities​. Twin Cities GLBT History Project. University of Minnesota Press. 2010. 30. 
45 ​Miss Major interviewed by Susan Stryker. GLBT Historical Society. Interview Date January 29, 
1998.http://docs.glbthistory.org/oh/Major1-29-1988_web.pdf. Accessed April 25, 2019. 
46 Miss Major Griffin-Gracy interviewed by AJ Lewis. ​New York City Trans Oral History Project​. Interview 
Transcript #054. December 16, 2017. 
https://s3.amazonaws.com/oral-history/transcripts/NYC+TOHP+Transcript+054+Miss+Major+Griffin-Gracy.pdf. 
Accessed April 26, 2019. 
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‘True transsexuals,’ it seemed, had to perform gender to such an extent that they put their safety  47
in jeopardy in order to meet the medical criteria for a diagnosis. For many trans people, this was 
not possible in day-to-day life. It is apparent from Major’s statement that Benjamin thought of 
the ability to successfully pass as the desired gender as a prerequisite for undergoing hormone 
therapy and possible surgical interventions. People he thought could pass not was not allowed to 
access hormones through a legitimate medical venue. In the 1963 edition of ​Sexology​ magazine, 
an anonymous trans person wrote to Benjamin asking about what they could do to “end” their 
“misery.”  In order to determine if a ‘sex change’ was appropriate to recommend, one of his 48
questions in response was,  
Is your general appearance and physical build such that you can pass as a woman, 
or is it possible you will look more like a man dressed up as a woman? Don’t ask 
the mirror, take the word of an objective outsider.  49
By this logic, a major consideration in a person’s decision to pursue transitioning had to be the 
viability of ‘success’ in the desired gender. However, the agency of the trans person to decide 
this for themself is displaced by the word of the “objective outsider,” who must determine if they 
could, in fact, pass. The sentiment that trans people are not ‘objective enough’ to determine 
whether they are trans or pass as their desired gender is strange, especially since there still to this 
day has been no successful diagnostic test that can conclusively determine if someone is 
47 ​Many trans people do not sufficiently ‘pass’ prior to undergoing hormonal and surgical interventions, thereby 
exposing them to social control and discipline for their gender transgressions in the form of extra legal (and legal) 
violence from strangers and law enforcement. This kind of violence did not fall on trans people indiscriminately; 
when asked about encounters with law enforcement and institutionalization, Miss Major replied:  
“...It happened to..well, not exactly ALL of us…there were a few that skated through, come from, you know money. 
So they do a lot, they do better than the rest of us. They actually get to be an older person without a record, or 
fingerprints or abuse from the police.” ​Miss Major Griffin-Gracy interviewed by AJ Lewis. ​New York City Trans 
Oral History Project​. 
48 ​Harry Benjamin, “I Want to Change My Sex!” in ​Sexology: Modern Guide to Sex Knowledge​. Gernsback. 
December 1963. 292. 
49 ​Harry Benjamin, “I Want to Change My Sex!,” 293-294. 
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transgender. Medical authority, then, is positioned as the objective outside eye that can discern 
the appropriateness of transition for trans people. 
Intrinsic to the success of medicalization is upholding the fiction that doctors and experts 
are objective outsiders that are immune from subjective thoughts, biases, and emotions. It is 
obvious, however, that Benjamin’s medical ‘objectivity’ was not such. Miss Major reflects on 
her impression of Benjamin: 
Personally, he only did girls he thought would pass. He only did white girls. He 
only did girls who were between, no one taller than 5’6’’. Would help those girls. 
So taller girls like myself had to find other places. The black girls had to go to 
other places. Stuff like that.   50
Major’s remarks beg the question: why did the doctor withhold treatment from black trans 
people who went to his office? Why did he not consider that these people were worthy of his 
medical care and attention? Trans historian Julian Gill-Peterson writes, “...the abstract whiteness 
projected onto the white trans body justified the attention given by doctors. Black trans and trans 
of color patients were much rarer because they were by design not welcome within that 
discourse.”  The medical discourse created by Benjamin about transness had little space to 51
accommodate the ‘treatment’ of Black trans people. Benjamin made choices, rooted in racism, 
about who was to be given access to a transition under the supervision of professionals. He made 
value judgments on the worthiness of Black trans people to receive medical attention.  
His decisions to deny access to hormone therapy and referrals for surgery had material 
effects on Black trans people’s lives and created no legitimate path for them to materialize the 
embodiment they desired. They were not going to stop pursuing hormone therapy, as evidenced 
by Miss Majors words ‘...the black girls had to find other places.’  They looked to the black 52
50 ​Miss Major Griffin-Gracy interviewed by AJ Lewis. New York City Trans Oral History Project.  
51 Julian Gill-Peterson, ​Histories of the Transgender Child​, 27. 
52 ​Miss Major interviewed by Susan Stryker, GLBT Historical Society. 
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market  to self-administer the care that the medical profession was unwilling to provide to them, 53
thereby creating an alternate means of materializing their desired embodiment outside of the 
dominant medical framework. In being forced to resort to obtain hormones outside of legitimate 
medical avenues, Black trans people were disenfranchised from accessing medical recognition as 
transsexual and subsequent understanding as such. The possibility that Black people were, in 
fact, trans at all was withheld by the medical model. Gill-Peterson writes, “...the whiteness of 
medicine interfere[s] with the intelligibility and livelihood of black, brown, indigenous, and 
other marginal trans people…”  Intelligibility, on the one hand, is a function of medicalization, 54
and its ability to make understandable and categorizable aids in the social control and discipline 
of trans people. On the other hand, it also facilitates access to a certain level of safety in pursuing 
a medical transition. Self-administering very strong drugs that need to be carefully monitored in 
the blood in order to ensure that damage is not done to organs such as the liver and heart is not 
optimal in terms of maintaining a healthy life, especially at a time when so little was known 
about them. Ceyenne Doroshow, a Black trans woman who lived in New York City in the early 
1970s, recounts the story of her role model, an older Black trans woman, who showed her how to 
inject estrogen and gave her her first dose.  This role model, who had been taking hormones 55
illegally for 30 years, died due to organ failure that was caused by unmonitored use of high doses 
of estrogen.  Black trans people were thus left to navigate the uncertainty of the black market 56
for hormones and surgical interventions. 
53 “Well there’s, there’s a black market. Hah! Anything you need and you want and have the money, you can get it.” 
Miss Major Griffin-Gracy interviewed by AJ Lewis. New York City Trans Oral History Project.  
54 Julian Gill-Peterson. ​Histories of the Transgender Child​. University of Minnesota Press. 2018. 28. 
55 Ceyenne Doroshow Interviewed by Cyd Nova, New York City Trans Oral History Project. Interview Date 
February 19, 2017. http://oralhistory.nypl.org/interviews/cayenne-doroshow-ejpsvu. Accessed April 30, 2019. 
56 ​Ibid. 
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The idea of ‘true’ transsexuality conferred a belief that the narratives Benjamin’s patients 
presented stemmed from real lived experience rather than a selective and highly performative 
re-reading of past events in one’s life. Schaefer and Wheeler write,  
Even without any books to read, without any other source of information, with or 
without childhood conditioning, with or without dystonic families, assuming that 
he or she was alone and unlike anyone else in the world, Benjamin's earliest 
patients came to him self-diagnosed, in that they described symptoms and 
conditions ​exactly as his patients continued to describe themselves throughout his 
30-year practice; and exactly as we continue to hear them describe themselves.  57
This assumes that Benjamin’s first patients exhibited some fundamental truth about the nature of 
transness. They completely overlook the fact that trans people had access to information, albeit 
limited, about their ‘condition’. Many read works published about transness and emulated the 
narratives and information that they found contained within  when talking to others, particularly 58
to medical professionals. In the next section, I will turn to a discussion about narratives and 
tropes surrounding trans identity in popular culture during mid-century. 
 
Christine Jorgensen, Trans Normativity, and ‘Leaving it to the Experts’ 
At the same time that medicalized trans identity was being formulated, the media 
circulation of Christine Jorgensen’s story brought ‘transsexuality’ to the attention of the larger 
U.S. public for the first time.  Jorgensen, a white trans woman, underwent hormone therapy and 59
a series of genital surgeries during the early 1950s in Denmark under the supervision of Danish 
endocrinologist Dr. Christian Hamburger. She attracted a storm of mainstream media attention 
57 ​Schaefer and Wheeler, Emphasis added. 
58 ​Meyerowitz, ​How Sex Changed,​ 47. 
59 ​Emily Skidmore, “‘Constructing the ‘Good Transsexual’: Christine Jorgensen, Whiteness, and Heteronormativity 
in the Mid-Twentieth-Century Press” in ​Feminist Studies, Vol. 37, No. 2, Race and Transgender Studies​, 270-300. 
Feminist Studies, Inc. 2011. 270. 
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beginning in 1952 when she the story of her ‘sex change’ was leaked to the press,  and 60
maintained it well into the early 1970s.  Jorgensen’s story popularly introduced the idea in the 61
U.S. of a non-psychological treatment path for the problem of transsexuality.  Jorgensen’s 62
whiteness, in conjunction with her hypervisibility in media, contributed to solidifying 
transsexualism as something that could only be intelligible when it was exhibited through 
whiteness. As historian Joanne Meyerowitz writes, Jorgensen was hyper-feminine, heterosexual, 
and blonde, “the hallmark of 1950s white feminine glamour.”  As her image circulated around 63
the world, in arguably the first instance of a trans person that was this highly publicized, people 
came to associate achieving "convincing and conventional”  white femininity with a successful 64
transition.  Thus, a successful medical transition was characterized by achieving and ever 65
striving towards normative white femininity. Feminist theorist Emily Skidmore writes, “...white 
transwomen were able to articulate transsexuality as an acceptable subject position through an 
embodiment of the norms of white womanhood, most notably domesticity, respectability, and 
heterosexuality.”  In other words, key to the process of establishing someone as an intelligible 66
‘transsexual’ was to construct them, apart from the fact of their transsexuality, as just like 
‘everyone else.’ To aspire to white feminine ideals (for trans women) was to aspire to achieve 
medicalized transsexual subjectivity, rendered socially acceptable and respectable by merit of its 
proximity to whiteness. 
60 ​Joanne Meyerowitz. ​How Sex Changed, ​66. 
61 ​Emily Skidmore, “‘Constructing the ‘Good Transsexual,’” 270. 
62 Meyerowitz, ​How Sex Changed,​ 73. 
63 Meyerowitz, 62. 
64 ​Meyerowitz, 63. 
65 ​Susan Stryker, ​Transgender History​, 47.  
66 ​Emily Skidmore, “‘Constructing the ‘Good Transsexual,’” 271. 
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For Jorgensen, creating ​the​ trans story involved a process of creating negative space 
against which to define herself. Jorgensen’s memoir, ​Christine Jorgensen: A Personal 
Autobiography ​published in 1967, distances herself from queerness. Any suspicions the reader 
might have that she had queer desires were thwarted in her memoir, which is very explicit that 
she was straight. She writes,  
During the months in service, I had seen a few practicing homosexuals, those 
whom the other men called ‘queer.’ I couldn’t condemn them, but I also knew that 
I certainly couldn’t become like them…  67
Faced with accusations that she was actually a gay man or a drag queen from the mainstream 
press, Jorgensen worked tirelessly to distance herself from queerness, and reassert again and 
again that she was not queer. I am not doubting the veracity of her sexuality; I am merely trying 
to point out that she contrasted herself, the ‘good’ transsexual, with the other, bad trannies and 
queers who violated social and sexual taboos. In her memoir, she recounts “with shock and 
disgust”  a man who made an unwanted advance on her before her transition, and writes, rather 68
dramatically, “I spun away from his lumbering figure and pushed blindly through the crowd of 
young people into the darkness outside, heading for the beach…I leaned over the edge of the pier 
and vomited.”  While part of her reaction certainly had to do with the feeling of being subjected 69
to an unwelcome flirtation, the severity of the disgust she describes is mostly related to the fact 
that it was a queer encounter. She tries to explain away the encounter with an appeal to the 
innateness of her femininity, wondering, “Was it my slight build, my blonde complexion? But 
what did bone-structure have to do with it? …there had to be some physical explanation for my 
difficulty.”  In so doing, she constructs herself as heterosexual and reifies her white femininity, 70
67 ​Christine Jorgensen. ​Christine Jorgensen, A Personal Autobiography.​ Bantam Books. 1967. 33. 
68 ​Jorgensen, ​A Personal Autobiography​, 74-75 
69 ​Jorgensen, 75. 
70 ​Ibid, 75-76. 
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in a way intentioned to gain sympathy from mainstream heteronormative society and assert that 
trans people were not homosexual. 
Christine’s story of pursuing “life and the freedom to live it,”  in other words, the ability 71
to be understood as transsexual so that she could access her desired embodiment, can be directly 
contrasted with the construction of black trans people’s lives during this time period. Indeed, 
Jorgensen’s narrative and public persona carefully contrasted her respectability against social 
deviants who deserved moral condemnation.  Black trans historian C. Riley Snorton’s book 72
Black on Both Sides​ tells the stories of black trans people whose stories emerged during the same 
time as Jorgensen’s, but largely remained confined to the black press. Snorton writes that telling 
these narratives does not simply ‘add’ the stories of Black trans people at mid-century, but 
“disrupt[s] the teleology of medicalized transsexuality as corporeal freedom.”  Carlett Brown, a 73
Black trans woman whose story emerged in the Black press in 1953, was characterized as a 
‘mimicker’ of Jorgensen by the press.  Brown’s life as a shake dancer, a stigmatized occupation, 74
was not welcome or accommodated for within the medical trans identity. She pursued a medical 
transition in Europe, but her plans were ultimately stunted by the federal government, which 
forbade her to leave the U.S. until she paid a $1,200 federal income tax debt. Regardless of if she 
actually underwent such a surgery, Brown and other Black trans women faced police harassment 
on a daily basis.  Thus, Snoton writes, “…Jorgensen’s spectacularized transsexual ‘freedom’ 75
71 ​Jorgensen, ​A Personal Autobiography, ​90. 
72 ​Jorgensen displays her feelings towards prostitutes: “I don’t see why you should feel anything toward her. Those 
people make me sick. It’s all right as long as they get away with what they’re doing, but once they get caught they 
weep and plead for mercy. She had her fun--now she has to pay the price.” Roy Ald, “Christine Jorgensen,” ​True 
Confessions, ​September 1954, 64, as quoted by Skidmore in “‘Constructing the ‘Good Transsexual,’” 277. 
73 ​C. Riley Snorton, ​Black On Both Sides: A Racial History of Trans Identity​. University of Minnesota Press. 2017 
Kindle Cloud Edition. 
74 ​Snorton, ​Black On Both Sides.  
75 ​ Snorton, ​Black On Both Sides. 
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was tethered to equally robust representations of radicalized unfreedom…”  Many Black trans 76
women were not intelligible as feminine or as real women in the way that Jorgensen was, 
because of their categorical distance from normative white femininity, and were thus left to be 
disciplined and controlled by law enforcement and errant violence alongside the freaks and 
anomalies that Jorgensen sought to distance herself from.  
Subjective experiences of trans identity at mid-century were not entirely tethered to the 
medical model; many people lived tangible and satisfying lives in non-assigned genders in ways 
that did not depend on the clinic. Take, for example, Ava Betty Brown, a black trans woman 
whose story emerged in a 1957 edition of black newspaper ​The Chicago Defender ​after she was 
arrested for wearing women’s clothes. While she was being tried, she defended her identity as a 
woman by asserting that everyone in her life knew her as such. She said, “Everything I own is in 
the name of Betty Brown…If I am a man, I don’t know it.”  While the paradigm of transexuality 77
as an exclusively medical phenomenon ascended, Black trans people did, in fact, assert a claim 
to a trans existence by using “an alternative set of relations--that of black sociality--as the site for 
her gender articulation…”  As evidenced by an article published 12 years later detailing an 78
arrest--again for crossdressing--revealed that police violence and harassment still animated 
Brown’s day-to-day life. Her plans to obtain surgery in Denmark were “indefinitely deferred.”  79
Thus, her claim to trans identity would remain in the social fabric of black life, never recognized 
as trans by the broader public or the medical establishment.  
76 ​Snorton, ​Black On Both Sides. 
77 “'Double-Sexed’ Defendant Makes No Hit with Jury,” Chicago Daily Defender, April 4, 1957, 
as quoted by Snorton in ​Black On Both Sides. 
78 ​Snorton, ​Black On Both Sides. 
79 ​Snorton, ​Black On Both Sides. 
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Jorgensen’s narrative helped reinforce the notion that transness was in fact a medical 
condition, the understanding of which should be left up to medical professionals and experts. In 
her memoir, she affectionately refers to the doctors she associated with, even going so far as to 
change her name to Christine, the feminine iteration of Christian, the first name of her 
endocrinologist in Denmark, Dr. Hamburger.  After her final surgery, she writes, “I felt at last 80
that I’d completed the transition to womanhood, and except for the inability to bear children, was 
as complete a person as I’d dreamed of being, both emotionally and physiologically.”  Only 81
once her genital surgery was ‘complete’ did she feel that she was a true woman, implying that 
the only way for trans people to achieve their desired gender identity was to undergo a 
‘complete’ surgical and hormonal transformation. She concludes her memoir on a positive note, 
remarking on the opening of the first gender identity clinic at Johns Hopkins University in 1966 
and the steady progress of medicine in relation to ‘transsexualism’. In a move to completely 
surrender her autonomous knowledge about her identity, she writes, “This book, then, is not 
meant to be a history of transsexualism or a study of its medical management. I leave that to the 
experts.”  In the following section, I turn to the university-based gender identity clinics as a site 82
for the construction of gender. 
 
The Gender Identity Clinic as a Site for the Construction of (trans)Gender 
Gender identity clinics adopted the medicalized model of transness, which 
institutionalized the standards, diagnostic criteria and treatments on a national scale, laying the 
groundwork for the professionalization of trans healthcare as a legitimate medical field. Between 
the late 1960s and the early 1970s, several university-based gender identity clinics cropped up 
80 ​Jorgensen, ​A Personal Autobiography​, 109. 
81 Jorgensen, ​A Personal Autobiography​, 228. 
82 Jorgensen, ​A Personal Autobiography​, 297. 
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around the U.S., and used Benjamins’ 1966 book ​The Transsexual Phenomenon​ as “their 
standard reference”.  The Johns Hopkins University Gender Identity Clinic opened in 1966, 83
making it the first hospital in the United States to surgically treat ‘transsexuals’ through gender 
affirmation surgeries, including bottom surgery.  The team consisted of plastic surgeons, 84
psychologists, psychiatrists, urologists, gynecologists, and one pediatrician.  Reed Erickson, a 85
transgender man and millionaire philanthropist, provided substantial funding to the gender 
identity clinics.  Gender identity clinics substantially increased the mainstream availability of 86
hormones and surgery in the U.S. and provided a legitimizing force for the professionals who 
provided such treatments for transness. The primary goal of such clinics, according to the head 
plastic surgeon of the clinic at Johns Hopkins, Dr. John Hoopes, was finding “a sound means of 
alleviating the problem of gender identification and of fostering public understanding of these 
extremely unfortunate individuals.”  This ultimately culminated in the production of a 87
standardized medical model for treating transsexualism.  88
Gender identity clinics engaged in a project of “grafting intelligibility onto the 
transsexual”  as a distinct medical disorder that could be treated only through hormone therapy 89
and surgical interventions intentioned to render the trans person as passing as possible. Part of 
83 ​Sandy Stone, ​The Empire Strikes Back: A Posttranssexual Manifesto. ​Published 1987. 
https://sandystone.com/empire-strikes-back.pdf. Accessed April 30, 2019. 
84 ​Meagan Day, “How one of America’s best medical schools started a secret transgender surgery clinic.” Timeline. 
Published Nov. 14, 2016. https://timeline.com/americas-first-transgender-clinic-b56928e20f5f. Accessed April 27, 
2019. 
85 Meagan Day, “How one of America’s best medical schools started a secret transgender surgery clinic.” 
86 ​Genny Beemyn, “Transgender History in the United States” in ​Trans Bodies, Trans Selves: A Resource for the 
Transgender Community​. Oxford University Press. 
https://www.umass.edu/stonewall/sites/default/files/Infoforandabout/transpeople/genny_beemyn_transgender_histor
y_in_the_united_states.pdf. 2014. 16. 
87 ​Dr. Hoopes as quoted by Jorgensen in​ A Personal Autobiography​, 296. 
88 Joanne Meyerowitz, ​How Sex Changed​, 224. 
89 Michael David Franklin, “Calculating Risk History of Medicine,” 29. 
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this process involved developing objective criteria beyond Benjamin’s that could reliably 
‘diagnose’ transsexualism. Trans author and activist Sandy Stone argues that these criteria 
functioned to actually produce gendered subjects, writing “The criteria constituted a fully 
acculturated, consensual definition of gender, and ​at the site of their enactment we can locate an 
actual instance of the apparatus of the production of gender​.”  Of roughly 2000 applications 90
received in the first two years that the Johns Hopkins clinic was open, only 24 were able to meet 
the criteria developed by these clinics.  After getting on a waiting list (the clinic only accepted 2 91
patients per month), trans people had to undergo extensive psychological and physical 
examinations, as required by the clinic, prior to receiving any kind of care.  “Only those who 92
show no signs of psychosis and appear to have a degree of insight into their condition are 
accepted…”  Patients were required to exhibit gender dysphoria at an early age, be attracted to 93
the “same biological sex,” have tried and failed to live in their assigned sex, be able to “pass” 
successfully if treatment is administered, and undergo a ‘real-life test’ of one year living as the 
desired gender.  Patients were expected to remain “heterosexual” after their gender-affirming 94
surgery was completed, and eventually marry.  Dana Beyer, a trans activist who went to the 95
Hopkins clinic in the 70s, remarked: “No one said this explicitly, but they certainly implied it, 
that the whole purpose of this was to get a vagina so you could be penetrated by a penis.”  96
90 Sandy Stone, ​The Empire Strikes Back: A Posttranssexual Manifesto. 
91 Genny Beemyn, “Transgender History in the United States,” 24.  
92 “The Johns Hopkins Hospital has quietly begun performing sex change surgery” ​The New York Times​. November 
21, 1966, as quoted by Jorgensen in ​A Personal Autobiography,​ 295. 
93 ​Ibid. 
94 ​Dallas Denny as quoted by Genny Beemyn in “Transgender History in the United States,” 17. 
95 Gianna E. Israel, Donald E. Tarver, and Joy Diane Shaffer. ​Transgender Care: Recom Guidelines, Practical Info​. 
Temple University Press. http://www.jstor.org/stable/j.ctt1bw1hmt. 1977. 
96 ​Rachel Witkin. “Hopkins Hospital: a history of sex reassignment.” The Johns Hopkins News-Letter. Published 
May 1, 2014. 
https://www.jhunewsletter.com/article/2014/05/hopkins-hospital-a-history-of-sex-reassignment-76004/. Accessed 
April 15, 2019.  
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Through creating criteria and conditions for treatment, the gender identity clinics defined further 
that ‘transsexualism’ was a label that would only be given to those who cooperated with 
medicine to reproduce normative gender in otherwise gender deviant persons. 
This highly selective process, rather than having the result of successfully ‘diagnosing’ 
transness, facilitated the exercise of medical control and regulation over the socially contentious 
force that was transness. Trans historian Michael David Franklin writes that the clinics careful 
production of transsexual subjects was intentioned to “...discipline the nonconformity that 
galvanized political ferment and to diagnose the insurgencies that convulsed the nation and 
undermined authority.”  Indeed, by constructing what counted as legitimately trans, these clinics 97
also constructed what did not constitute a trans subject along the lines of race, class, nationality, 
and sexualty. Trans historian Julian Gill-Peterson critiques the gender identity clinics, writing,  
The overwhelming majority of trans patients seen at institutions of medicine were 
white. Even in the most pathologizing and disenfranchising medical models, the 
abstract whiteness projected onto the white trans body justified the attention given 
by doctors. Black trans and trans of color patients were much rarer because they 
were by design not welcome within that discourse.  98
The Black and trans of color people who were excluded from treatment at Johns Hopkins and 
other gender identity clinics were denied access to the medical trans identity because they did not 
aid in its project of producing successful patients who would uphold the normative gender, 
sexuality, and whiteness. Good transsexuals would ultimately become productive citizens who 
contributed to society through respectable lives that involved legal employment,  marriage, and 99
social intelligibility. 
97 ​Franklin, “Calculating Risk,” 28. 
98 ​Gill-Peterson, ​Histories of the Transgender Child​,  27. 
99 ​Franklin, “Calculating Risk,” 31.  
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The ultimate goal in the treatment of transsexualism was to produce subjects that were 
visually and socially legible in their binary gender of choice. Sandy Stone, discussing the gender 
identity clinic at Stanford, writes that staff selected candidates for surgery based on an 
“individual ​sense​” of the suitability of each patient for passing as their desired gender.   She 100
quotes Dr. Norman Fisk, head of the clinic as saying, “I now admit very candidly that...in the 
early phases we were avowedly seeking candidates who would have the best chance for 
success​.”  Rather than the goal being a successful, meaning without complications, surgery, 101
success is defined in terms of achieving passing status on the part of the trans person. This 
particular clinic functioned as a “charm school” in that it sought to teach patients how to “behave 
like” women, “...i.e. ​gendered​ females.”  Indeed, these clinics understood very well that gender 102
was, in fact, learned. Harry Benjamin, responding to an anonymous trans person seeking medical 
intervention in 1963, gave the following advice on passing:  
When you have recovered from the pain and the after-effects of the operation, 
after a few weeks or months, your real work begins—to change into a ‘woman.’ 
You have to learn how to behave like a woman, how to walk, how to use your 
hands, how to talk, how to apply make-up and how to dress.  103
Defining success in terms of passing profoundly restricted the possibilities for trans people who 
could not or did not want to pass to access medical services under the newly emerging 
professional model of treatment.  
The obstacles set up by the gender identity clinics were put in place with the intention of 
only providing access to those trans people who fit their criteria. Some trans people, however, 
found creative ways of getting around this model and achieving the embodiment they desired. 
100 ​Stone, ​The Empire Strikes Back.  
101 ​Ibid. 
102 ​Ibid. 
103 Benjamin, “I Want to Change My Sex!,” 294. 
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Joanne Meyerowitz illustrates that some trans women in the late 1960s, who had adopted a 
“casual, unisex, hippie style”  advised each other on how to get around the system.  104
...their transsexual friends told them they had to dress up as conventionally 
feminine women…[t]hey also warned one another to refrain from mentioning 
certain details about their sex lives, especially if they took pleasure from their 
genitals or intended to live as homosexuals after their surgery.  105
Many of the researchers who kept hearing the same stories and seeing the same types of people 
over and over again, “whose behavior matched up gratifyingly with Benjamin’s criteria,”  took 106
this to mean that they had finally discovered some inherent truth about transsexuality. Trans 
people, simply wanting to access hormones and surgery, sought to get around this system, telling 
the researchers exactly what they wanted to hear. Stone writes that this cyclical pattern “seems a 
recipe for an uneasy adversarial relationship”  between trans people and medical professionals. 107
This relationship remains uneasy to this day. 
Gender identity clinics were closed down following the 1979 publication of a much 
discredited study  by Dr. Jon K. Meyer and Donna J. Reter of Johns Hopkins that concluded 108
trans people who received surgical interventions were not more well adjusted to life 
postoperatively as compared to transgender people who did not receive surgery. Dr. Meyer was a 
psychologist that maintained the belief that the phenomenon of transness was an inherently 
psychological problem that could not be solved through hormonal or surgical therapies. Meyer 
told the ​New York Times​ in 1979, “My personal feeling is that surgery is not proper treatment for 
a psychiatric disorder, and it’s clear to me that these patients have severe psychological problems 
104 ​Meyerowitz, ​How Sex Changed, ​226. 
105 ​Ibid. 
106 ​Stone, ​The Empire Strikes Back. 
107 ​Ibid. 
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that don’t go away following surgery.”  The study measured adjustment through the post-op 109
trans person’s adherence to a heteronormative livestyle following surgery. The researchers 
assigned each subject a score in order to measure their adjustment; things that earned positive 
points were improvements in job level and heterosexual marriage/cohabitation, while arrests, jail 
sentences, decline in job level, psychiatric treatment, and “nongender appropriate cohabitation or 
marriage.”  Meyer’s study reinforced the notion that the goal of treating trans people was to 110
produce productive subjects that aligned with normative gender, sexuality, middle-class values, 
and whiteness. The study, though it was widely criticized by doctors and researchers alike, 
however, this study was all that was needed to topple the gender identity clinic system that had 
emerged only 13 years earlier. 
In the next chapter, I turn to the emergence of professional associations that implemented 
a standardized model for the medical management of transness following the closure of gender 
identity clinics. 
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Chapter 2  
Gatekeeping Trans Healthcare: Passing the Diagnostic Test/Passing in the Streets   
 
“How do you know you want rhinoplasty, a nose job?” he inquires, fixing me 
with a penetrating stare. 
 
 “Because,” I reply, suddenly unable to raise my eyes above his brown wingtips, 
“I’ve always felt like a small-nosed woman trapped in a large-nosed body.”  
 
“And how long have you felt this way?” He leans forward, sounding as if he 
knows the answer and needs only to hear the words. 
 
 “Oh, since I was five or six, doctor, practically all my life.” 
 
 “Then you have rhino-identity disorder,” the shoetops state flatly. My body sags 
in relief. “But first,” he goes on, “we want you to get letters from two 
psychiatrists and live as a small-nosed woman for three years . . . just to be sure.”
 111
 
Introduction 
The standardization of trans healthcare that took place between the 1980s and the current 
moment institutionalized and refined the model of care developed by Harry Benjamin and his 
associates at the university-based gender identity clinics. Now referred to as the gatekeeping 
model, it functions to sort those who meet the diagnostic criteria from those who do not, thereby 
regulating access to transition-related healthcare. What are the politics of installing a gatekeeping 
mechanism in the form of a mental health professional? How is gender dysphoria diagnosed? 
How can we balance maintaining access to care within a pathological framework? What modes 
of existence are allowed to be considered diagnosably trans?  Why are authentic narratives of the 
self illegitimate under this model? I argue that the gatekeeping model is aimed at controlling, 
111 Riki Anne Wilchins, ​Read My Lips: Sexual Subversion and the End of Gender, ​63, as quoted by Dean Spade in 
“Resisting Medicine, Re/modeling Gender” in ​Berkeley Women’s Law Journal, Vol. 15​, 15-27. 
http://www.deanspade.net/wp-content/uploads/2010/07/resisting.pdf. 2003. 15. 
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disciplining, and regulating the expression of gender variance and restricting trans people’s 
ability to access the embodiment they desire under the care of a medical professional.  
 
Standardizing Trans Medicine in the Private Sphere 
With the closure of gender identity clinics in 1979, the medical management of trans 
people largely relocated to the sphere of private practices. In 1978, medical professionals who 
worked in the budding field of trans healthcare established the Harry Benjamin International 
Gender Dysphoria Association (HBIGDA).  HBIGDA released the first professional guidelines 112
on treating ‘transsexuals’ in 1979, the same year that the clinics began closing. The Standards of 
Care (SOC) were created in order to standardize the medical treatment provided by professionals 
at private practices,  who were now expected to follow the “minimal requirements”  outlined 113 114
in the standards. While these standards were not legally binding, they established that uniform 
professional standards in the treatment of ‘transsexuals’ were necessary to provide appropriate 
‘care’. By creating this document, the HBIGDA constructed itself as the leading medical 
authority on transness and the sole professional group authorized to determine how treatment 
was to be rationed. 
By adopting the psychiatric diagnosis “transsexualism” from the 1980 DSM-III, the SOC 
solidified that there was to be a regulatory mechanism, a gatekeeper, that rationed out the 
‘treatment’ in a way that reinforced medicalized transness and binary gender. The original SOC 
required people who sought ‘sex reassignment’ to acquire multiple recommendations from 
clinical behavioral scientists with extensive credentials in order to access hormones and surgery.
112 ​Meyerowitz, ​How Sex Changed​, 255. 
113 ​Standards of Care​, Harry Benjamin International Gender Dysphoria Association, 1981. 
114 ​Ibid, 2. 
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 These mental health professionals were to be gatekeepers, tasked with sorting, classifying, and 115
diagnosing transsexualism in suitable candidates. The decision to write a recommendation letter 
largely centered around how well a person matched the DSM-III diagnosis for ‘transsexualism,’ 
which outlined the diagnostic criteria as follows: experiencing a “sense of discomfort...about 
one’s anatomic sex,” a “wish to be rid of one’s own genitals and live as a member of the other 
sex,” “the disturbance has been continuous...for at least two years,” and is exhibited in the 
“absence of physical intersex or genetic abnormality, and is “not due to another mental disorder, 
such as schizophrenia.”  Whether or not a person met these criteria was to be established during 116
a therapeutic relationship, which needed to last “at least three months”  prior to starting 117
hormone therapy and “at least six months”  prior to genital/breast surgery. Surgical access was 118
to be more heavily regulated; in addition to at least 6 months of counseling prior to making a 
diagnosis and recommendation, the initial decision to allow access to surgery was to be subject 
to “peer review” by another independent clinical behavioral scientist.  Clearly, the authors of 119
the SOC felt that it was important to have several roadblocks in place, in particular emphasizing 
time and careful professional decision-making when selecting an appropriate candidate to 
receive treatment.  
The SOC were especially concerned with guarding against ‘hormones on demand,’ or 
access to ‘treatment’ on the transsexual’s terms, which was to be avoided at all costs. The third 
version of the Standards, published in 1980, read, “[h]ormonal and surgical sex reassignment are 
procedures requiring justification and are not of such minor consequence as to be performed on 
115 ​Standards of Care,​ 1981, 4-6. 
116 ​Ibid, 9. 
117 ​Ibid, 12. 
118 ​Ibid, 14. 
119 ​Ibid, 13. 
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an elective basis.”  By emphasizing that trans people do not have the capacity to make 120
important decisions about their bodies and lives, the gatekeeping model sought to ensure that 
each candidate was scrutinized as thoroughly as possible in order to prevent trans people from 
making a rash or misguided decision. The first standard in the original SOC reads as follows: 
Hormonal and/or surgical sex reassignment on demand (i.e., justified simply 
because the patient has requested such procedures) is contraindicated.  It is 121
herein declared to be professionally improper to conduct, offer, administer or 
perform hormonal sex reassignment and/or surgical sex without careful evaluation 
of the patient’s reasons for requesting such services and evaluation of the beliefs 
and attitudes upon which such reasons are based.  122
Medicalizing trans identity as a disorder was predicated upon solidifying the notion that it could 
not be understood or diagnosed by lay-people: professionals had to maintain authority over the 
power to diagnose. Speech act theory posits that words are capable of doing things or bringing 
things into reality: for example, when a justice of the peace says, “I now pronounce you husband 
and wife,” those two people are now married by virtue of that statement. The positionality of the 
speaker matters because only words that come from certain mouths have the power to 
accomplish certain acts. To diagnose oneself is an oxymoron: it is simply not possible to 
diagnose yourself because diagnosis is only made possible through the removal of autonomous 
sources of knowledge about the self. By establishing a gatekeeping mechanism, trans people 
were rendered unable to perform the ‘speech act’ of declaring themselves trans in any 
meaningful sense within a medical context. Allowing trans people to simply request and receive 
the medical procedures they desired would allow those whose very existence threatened the 
120 “In recent decades, the demand for sex reassignment has increased as have the number and variety of possible 
psychologic, hormonal and surgical treatments.” Ibid, 6-7. 
121 ​Contraindicated, in medical terms, means that a procedure or treatment is inadvisable due to other factors, such 
as a preexisting condition or circumstance.  
122 ​Ibid, 7.  
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binary to pass through, threatening the very stability of the medicalized framework that was built 
to control and discipline deviant gender expression. 
The early SOC included a standard that required individuals seeking ‘sex reassignment’ 
to undergo a ‘real-life test’ by living full-time in the gender of choice. It reads, “Genital sex 
reassignment shall be preceded by a period of at least 12 months during which time the patient 
lives full-time in the social role of the genetically other sex.”  This assumes that only once the 123
trans person has consulted with a therapist will they actually begin navigating the world 
‘full-time’ as another gender. Not only does this preclude possibilities for expressions of gender 
deviance outside of the medical framework, it also reifies binary gender by implying that the 
person must have a consistently binary gender expression at all times for a full year. 
Additionally, there are many factors that would make it difficult for people to live “full-time” as 
another gender other than the legitimacy of their transness, namely: employment discrimination, 
familial relationships, violence on the street upon being clocked, or simply not wanting to do that 
because their gender expression was fluid.  
 Professional medical associations other than HBIGDA also participated standardizing the 
diagnosis and treatment of transness. The American Psychiatric Association (APA) developed its 
first diagnostic criteria for ‘transsexualism’ in 1980. The DSM, the diagnostic manual produced 
the APA, is the authoritative text used by medical professionals to diagnose and treat mental and 
behavioral health disorders. The DSM-III, published in 1980, included the diagnosis 
‘transsexualism’ and categorized it under psychosexual disorders.  By 1994, the DSM shifted 124
123 ​Ibid, 14. 
124 ​Jack Drescher, “Queer diagnoses revisited: The past and future of homosexuality and gender diagnoses in the 
DSM and ICD” in ​International Review of Psychiatry, Vol. 27 Issue 5​, 386-395. Taylor & Francis. October 2015. 
390. 
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to using the diagnosis ‘gender identity disorder.’  The most recent version, the DSM-5, was 125
published in 2013 with the updated diagnosis of “gender dysphoria.”  Looking in the table of 126
contents for the DSM-5, nestled under a whole host of diagnostic terms for mental disorders such 
as “Obsessive Compulsive and Related Disorders” and “Dissociative Disorders,” lies “Gender 
Dysphoria” as its own category of disorder.  In order to activate access to gender-related 127
hormones and/or surgery, people seeking these procedures must often obtain a diagnosis for 
gender dysphoria from a qualified mental health professional. They describe gender dysphoria 
as, “...the distress that may accompany the incongruence between one’s experienced or expressed 
gender and one’s assigned gender...many are distressed if the desired physical interventions by 
means of hormones and/ or surgery are not available.”  In the diagnostic features for 128
adolescents and adults, which is separate from the ones for children,  it reads that the “core 129
component” of gender dysphoria is experiencing a “marked incongruence” between the gender 
assigned at birth and the person’s “experienced/expressed gender.”  This incongruence is 130
marked by a “strong desire to be rid of one’s primary and/or secondary sex characteristics” and a 
“strong desire for the primary and/or secondary sex characteristics of the other gender.”  131
125 ​Drescher, “Queer diagnoses revisited,” 390. 
126 ​The American Psychiatric Association uses the DSM-5 definition​ of ​Gender Dysphoria, which “​involves a 
conflict between a person's physical or assigned gender and the gender with which he/she/they identify. People with 
gender dysphoria may be very uncomfortable with the gender they were assigned, sometimes described as being 
uncomfortable with their body (particularly developments during puberty) or being uncomfortable with the expected 
roles of their assigned gender. People with gender dysphoria may often experience significant distress and/or 
problems functioning associated with this conflict between the way they feel and think of themselves (referred to as 
experienced or expressed gender) and their physical or assigned gender.” See 
https://www.psychiatry.org/patients-families/gender-dysphoria/what-is-gender-dysphoria for more information.  
127 ​American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. 
American Psychiatric Association. Arlington, VA. 2013. 
128 ​Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, 451. 
129 ​Ibid.  
130 Ibid, 453. 
131 ​Ibid, 452. 
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While the DSM-5 was being written, the APA created the DSM-5 Work-group on Sexual 
and Gender Identity Disorders to deal with the contested diagnosis of gender identity disorder. 
LGBTQ activists demanded that the APA eliminate all gender diagnoses on the grounds that they 
were pathologizing and subjected trans people to unnecessary stigma.  The work-group, on the 132
other hand, was concerned that this would reduce access to care because health insurance 
providers refuse to reimburse for treatment without a diagnosis. One of the people in the 
work-group, Jack Drescher, reflects on the deliberation process:  
In an effort to balance these conflicting concerns between stigma and access to 
care, this author cautioned ‘first do no harm.’ In following this approach, APA’s 
decision to retain the DSM gender diagnoses appears justified and it has had the 
intended effect of improving access to care.  133
This tension between pathologization and maintaining access to care is central to the politics of 
trans healthcare. How do we balance these two concerns in a context where gender variance must 
be pathologized in order to facilitate access to hormone therapy and surgical interventions? 
When do we prioritize one over the other? 
 
WPATH and Gatekeeping Today 
HBIGDA was renamed the World Professional Association for Transgender Health 
(WPATH) in 2006 and remains the leading medical authority on trans health issues in the world.
 It has since released 7 updated standards of care that have evolved alongside and in concert 134
with the DSM, substantially relaxing the criteria  to access a diagnosis and treatment for what 135
is now known as gender dysphoria, particularly when it comes to accessing hormone therapy. It 
132 ​Drescher, “Queer diagnoses revisited,” 392. 
133 ​Drescher, “Queer diagnoses revisited,” 393. 
134 ​Mission and Vision​, World Professional Association for Transgender Health. 
https://www.wpath.org/about/mission-and-vision. Accessed April 30, 2019. 
135 ​DSM-5, 451-459. 
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still maintains the gatekeeping model that emerged in the original standards, recommending that 
trans people seeking medical services must first consult with a mental health professional. If the 
mental health professional diagnoses the person with gender dysphoria, they must write a referral 
letter for the person’s desired physician or surgeon.  One referral from a mental/behavioral 136
health professional is required to start hormone therapy and/or chest/breast surgery, while genital 
surgery requires two referrals, 12 months of continuous hormone therapy, 12 months of the 
‘real-life’ test,  and strongly recommends regular mental health counseling.   137 138
By placing gender dysphoria in the DSM-5 as a mental disorder, all of the ‘symptoms’ of 
the disorder are rendered internal struggles that are due to an inherent pathology present in the 
trans person. Professor of psychology Sarah Schulz argues that the DSM-5’s description of 
gender dysphoria as being characterized by “...clinically significant distress or impairment in 
social, occupational, or other important areas of functioning,”  rules out the reality that this 139
distress is not due to an inherent condition or pathology, but “...society’s ​response​ to 
nonnormative gender presentation.”  Kristen P. Lovell, a black trans woman who grew up in 140
Yonkers, NY, speaks to this in an interview with the ​Trans Oral History Project​ as she recounts 
her experiences being bullied and suspended from elementary and middle school:  
…when we are grappling with these things, we are the problem. And so, they put 
me in a classroom for ‘emotionally disturbed children.’ But it was just like, I’m 
136 ​Sarah L. Schulz, “The Informed Consent Model of Transgender Care: An Alternative to the Diagnosis of Gender 
Dysphoria” in ​Journal of Humanistic Psychology, Vol. 58, Issue 1​, 72-92. Sage. 2017. DOI: 
101177/0022167817745217. 74. 
137 The ‘real-life’ test involves living ‘full-time’ as the desired gender identity. It has been widely criticized as 
unnecessary. 
138 ​Standards of Care, Version 7. World Professional Association for Transgender Health. Published 2011. 
https://www.wpath.org/publications/soc. Accessed April 30, 2019. 
139 DSM-5, 453. 
140 ​Schulz, “The Informed Consent Model of Transgender Care,” 77. 
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not really emotionally disturbed. I’m disturbed by the fact that I’m being 
constantly being harassed on a daily basis…I have no choice but to lash out.  141
By segregating Lovell into a ‘special classroom,’ her teachers maintained that the reason that she 
lashed out at the children who bullied her was because she had some pathological emotional 
issue. The distress she experienced as a result of her harassment by other children’s was thus 
taken to be her fault, rather due to the harassment that she underwent because of their reactions 
to her nonnormative gender presentation. This logic is profoundly disempowering for trans 
people and fails to correctly attribute the source of the ‘distress and impairment in social 
functioning’ that many experience. Schulz problematizes this, writing, “...transgender identity 
itself is not necessarily a cause of distress, but instead is a ​valued​ life experience among 
transgender individuals who see being transgender as a way to live a satisfying and meaningful 
life.”   142
Gatekeeping forces trans people to present self-narratives rooted in distress and 
selectively read back on their lives through a lens of pathology, rather than explaining their true 
lived experience. Trans activist and attorney Dean Spade reflects on his own experiences 
navigating the gatekeeping model, 
So now, faced with these questions, how do I decide whether to look back on my 
life through the tranny childhood lens, tell the stories about being a boy for 
Halloween, about not playing with dolls? What are the costs of participating in 
this selective recitation? What are the costs of not participating?   143
By forcing trans people to participate in a ‘selective recitation’ of their lives, gatekeepers 
actually force them to pathologize themselves. Those who do not are not legible as trans, and are 
thus excluded from this category, thereby rendering access to mainstream hormones and surgery 
141 ​Kristen P. Lovell interviewed by Michelle Esther O’Brien. NYC Trans Oral History Project. Date of Interview 
April 4, 2019. http://oralhistory.nypl.org/interviews/kristen-p-lovell-de9cdr. Accessed April 28, 2019. 
142 ​Schulz, “The Informed Consent Model of Transgender Care,” 78-79. 
143 Spade, “Resisting Medicine, Re/modeling Gender,” 20.  
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all but impossible. Additionally, it puts trans people into a position where they are coerced into 
performing distress, impairment, and binary gender aspirations in order to be allowed to access 
this “world of meaning.”   Not only does this enforced narrative obscure the trans person’s true 144
desires and goals for their embodiment, it also renders the therapeutic relationship completely 
ineffective as a form of counseling. The goal of any therapeutic relationship should be to build a 
relationship based on trust, honesty, and respect for the patient’s autonomy. Here, it is more 
interested in perpetuating the gender binary and maintaining medicalization of the trans 
experience. 
In order to successfully analyze the narratives that trans patients put forth in the 
therapeutic setting, mental health professionals often rely on their own subjective understandings 
of how gender and transness operate. James Whitehead et al. conducted a study of 35 “trans 
positive” therapists in San Francisco and Portland, Oregon and focused on the instances in which 
they denied access to hormones or surgery to trans people who came to them seeking 
recommendations. One therapist recalled when she denied a letter to a client: 
The first time she had come in to see me she says ‘you know, I met a 
female-to-male transsexual last week, and I knew instantly that I was a, I needed 
to do the same thing. I needed to be a man’. And it never occurred to her before 
that. And here she was in her late twenties. Nobody I had ever seen before told me 
that, had told me that things occurred in a few hours. I stayed with it for a while, 
what I kept trying to get her to do was to talk about her full life with this issue. 
And, she kept arguing with me that the forces of the universe were telling her that 
she needed to transition. And my alarm’s going off right away that this is not a 
standard case, this person needs to not go there. This was a woman; she was a 
woman and should stay that way for her own good. And eventually she got fed up 
with me because I kept asking her for some particulars about what it must feel 
like to be a man; what her history has been.   145
144 ​Spade, “Resisting Medicine, Re/modeling Gender,” 22. 
145 ​Jaye Cee Whitehead, Jennifer Thomas, Bradley Forkner and Dana LaMonica, “Reluctant gatekeepers: 
‘Trans-positive’ practitioners and the social construction of sex and gender” in​ Journal of Gender Studies, Vol. 21, 
no. 4, ​387-400. December 2012. 
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When people enter into a situation with a mental health gatekeeper and do not provide the 
scripted narrative that is expected of them, this creates uncertainty on the part of the mental 
health professional. Because the gatekeeper felt alarmed by her lack of certainty on the validity 
of the claims this client made and their non-standard narrative, she doubled down on her 
authority and role as a gatekeeper and blocked access to the desired treatment. What’s more, she 
decided that this patient “was a woman” and should “stay that way for her own good,” 
completely dismissing that there was any reality to the claims to transness that this client was 
making.  
One justification for maintaining the gatekeeping model is to ensure that people do not 
regret their decision to transition, either as a result of a misdiagnosis or a poor decision, and hold 
the provider liable. In one study, 74% of providers interviewed were concerned about trans 
patients suing them who regretted their decision to pursue transition-related care.  ​Jamison 146
Green, former president of WPATH and trans man himself, remarks on the necessity of a 
therapist’s evaluation: “This is a complex and difficult thing, and if someone wants surgery it can 
be important that they slow down just a bit and think about what they’re doing.”  This logic is 147
animated partially by the medical doctrine of non-malfeasance, which contains the utmost 
principle that medical professionals should follow: ‘first do no harm.’ Gatekeeping suggests that 
if trans people wait an appropriate amount of time and talk to mental health professionals, then 
they will make a better and more prepared decision regarding whether or not to pursue surgery, 
146 ​Stef M. Shuster, “Performing informed consent in transgender medicine” in ​Social Science & Medicine Vol. 226​, 
190-197. 2019​. ​194. 
147 Evan Urquhart, "Gatekeepers vs. Informed Consent: Who Decides When a Trans Person Can Medically 
Transition?" ​Slate​. Published March 11, 2016. 
https://slate.com/human-interest/2016/03/transgender-patients-and-informed-consent-who-decides-when-transition-t
reatment-is-appropriate.html. Accessed April 28, 2018.  
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thus preventing possible regret. Diagnosis is also seen to play a role in preventing regret: if the 
patient is carefully evaluated, then information might surface indicating that the person is not 
trans and avoid a misdiagnosis that could potentially lead to a mistaken decision to undergo a 
transition. This works in line with the logic that transness itself is something that can actually be 
diagnosed. In sum, prevention of regret is thus prioritized over all else, including the wellbeing 
of the trans person seeking the medical care.  
Paddy McQueen, an ethicist and political theorist, problematizes the notion that regret is 
somehow linked to flawed decision-making and is to be avoided at all costs. He argues that 
withholding medical treatment for fear that a patient might later regret the decision disregards the 
autonomy of the patient. “Part of respecting a person’s autonomy is allowing them to make 
decisions that could later be regretted, so long as the decision can be justified at the time it is 
made.”  Trans people are thus deprived of a fundamental facet of adult life, which is the power 148
to make decisions for oneself. Part of being human is to make decisions that we regret. Further, 
the anxiety about trans people regretting a decision to undergo hormone or surgical interventions 
ignores the fact that the vast majority of trans people do not experience post-transition regret. 
Regret rates amongst trans people who undergo hormone therapy are low, with one study 
pointing to a .08% prevalence of regret in a group of 1,944 patients, just 17 people, and only 3 of 
them took steps to reverse their transitions.  None who regretted their decision took legal action 149
against the providers.   150
148 ​Paddy McQueen, "The Role of Regret in Medical Decision-making” in ​Ethical Theory and Moral Practice, Vol. 
20, no. 5.​ 1051-1065. https://doi.org/10.1007/s10677-017-9844-8. Nov 2017. 
149 Madeline B. Deutsch, “Use of the Informed Consent Model in the Provision of Cross-Sex Hormone Therapy: A 
Survey of the Practices of Selected Clinics” in ​International Journal of Transgenderism, Volume 13​, pp. 140-146. 
Routledge. 2011. DOI:10.1080/15532739.2011.675233. 141. 
150 ​Ibid. 
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The therapist-patient relationship does not occur within a vacuum. Race, class, and 
gender all inform and shape interactions that take place between the therapist and patient. 
Researchers B. Mitchell Peck and Sonya Conner conducted a study that found “...doctor-patient 
interactions will be most physician-centered between white physicians and non-white patients, 
male physicians and female patients, and for patients from lower socioeconomic backgrounds.”
 Black trans and trans of color people who seek medical care under the gatekeeping model are 151
thus subjected to higher levels of medical authority and paternalism in the decision-making 
process about their suitability to access transition-related medical services. Sociologist Emily 
Allen Paine quotes Corey, a Black 32-year-old nonbinary trans man, “I think there are 
interactions where it’s really difficult to tell what’s affecting the treatment...I don’t know what 
problem you’re having with me, but you’re having a problem.”  This confusion and dissonance 152
on the part of the patient puts them in a position where they are constantly uncertain about what 
it is about them that the therapist is attempting to discipline.  
Gatekeeping precludes the possibility of fostering an actual therapeutic relationship 
between the mental health professional and the trans patient. In other words, the goal of this 
therapy is not to provide counseling or guidance for trans people that they might actually benefit 
from. Therapists, because their role is to scrutinize, discern, and diagnose, often do not trust their 
trans patients and suspect that they are being dishonest.  Riley, a Filipino-American trans man, 153
151 B. Mitchell Peck and Sonya Conner, “Talking with Me or Talking at Me? The Impact of Status Characteristics on 
Doctor-Patient Interaction” in ​Sociological Perspectives, Vol. 54, No. 4 ​(Fall 2011), 547-567. SAGE. Fall 2011. 
https://www.jstor.org/stable/10.1525/sop.2011.54.4.547. 552. 
152 Emily Allen Paine, “Embodied Disruption: ‘Sorting Out’ gender and nonconformity in the doctor’s office” in 
Social Science and Medicine, Volume 221​, 352-358. Elsevier. 2018. 
153 ​Shuster, “Performing informed consent in transgender medicine,” 194. 
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describes his encounter with a mental health professional who had never seen a trans client 
before:  
...it felt like she was going line by line, asking me about my relationship to my 
body, my sex life…by that reasoning, concluded that I was actually not trans. 
Because I let partners touch me and because I can shower. And her way of 
describing to me that she didn’t believe me was that like, well these people do this 
and this, and these people can barely do this and that, and so I do not think that 
this is what you’re going through.  154
As we can see from Riley’s encounter, honesty is dangerous when interacting with gatekeepers, 
because no matter how often or how convincingly trans patients explain that they are trans, 
unless they reciting the medical trans script they will not be believed by the gatekeeper. Emily 
Paine quotes Dana, a 25-year-old Black non-binary person, who reflects on their experiences not 
being taken seriously or believed by healthcare providers. “I wonder if the reasons why my pain 
is not believed is maybe because of my class background, my race, and the gender that they’re 
perceiving me as.”  Black and trans of color people have a harder time convincing gatekeepers 155
that they are trans because their lives are not as intelligible as trans under the medical paradigm. 
Whatever the reasons why Dana’s healthcare providers do not believe them, their lack of trust for 
Dana has a serious impact on Dana’s health and wellbeing. What’s more--distrust for trans 
people on the part of gatekeepers creates situations in which access to hormones and surgery can 
be refused based on a disbelief in the patient’s self-proclaimed gender identity. 
Trans people seeking hormone therapy or surgery are very aware of the gatekeeping 
model and have adapted to life under a severe regulatory mechanism for enforcing binary 
gender. They recognize that they are being tested and evaluated, so they lie to the best of their 
ability. They lie to ‘pass’ the test, successfully convincing the therapist that their ultimate goals 
154 ​Paine, “Embodied Disruption,” 356. 
155 ​Ibid. 
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from treatment is ‘passing’ in the streets. Since Benjamin’s publication of ​The​ ​Transsexual 
Phenomenon​, trans people have been educating themselves and rehearsing performing what 
medical professionals expect them to say.   Trans author Claudine Griggs wrote in 1998, “I’ll 156
lie my ass off to get what I have to.”  When the costs of not lying are so severe that one’s 157
desired embodiment could be withheld from them, how could they not? Whether it be through 
friends, partners, or the internet, Sarah Schulz writes that trans people know what the diagnostic 
criteria are and are often “...ready to say what is expected of them to get the letter from the 
therapist...”  Gatekeeping produces highly performative narratives of transness that are 158
intentioned to satisfy arbitrary diagnostic criteria. As Spade writes, trans people have to  “...lie 
and cheat their way through the medical roadblocks to get the opportunity to occupy their bodies 
in the way they want.”  159
 
Informed Consent 
In recent years, trans activists and health care activists have been pushing for uniform 
adoption of the informed consent model as a patient-centered alternative to the gatekeeping 
model. Informed consent is grounded in the idea that patient autonomy should be respected in the 
decision-making process about whether or not to pursue transition-related care, and therefore the 
156 ​“...when the first transsexuals were evaluated for their suitability for surgery, their behavior matched up 
gratifyingly with Benjamin’s criteria...It took a surprisingly long time--several years--for the researchers to realize 
that the reason the candidates’ behavioral profiles matched Benjamin’s so well was that the candidates, too, had read 
Benjamin’s book, which was passed from hand to hand within the transsexual community, and they were only too 
happy to provide the behavior that led to acceptance for surgery.” Sandy Stone, The ​Empire​ Strikes Back: A 
Posttranssexual Manifesto. Originally Published 1987. https://sandystone.com/empire-strikes-back.pdf. Accessed 
April 15, 2019. 
157 Claudine Griggs, ​S/He: Changing Sex and Changing Clothes​, 1998, 32 as quoted by Dean Spade in “Resisting 
Medicine, Re/modeling Gender,” 23. 
158 ​Schulz, “The Informed Consent Model of Transgender Care,” 79. 
159 ​Spade,“Resisting Medicine, Re/modeling Gender,” 23. 
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involvement of a mental health professional is not necessary. In terms of how it looks, the 
patient, after hearing benefits, risks, and alternatives associated with a given treatment path, 
makes their own decisions about the care they would like to receive. Ruben Hopwood, the 
Transgender Health Program Coordinator at Fenway Health, a LGBTQ health clinic in Boston, 
described informed consent to a Rewire reporter as follows: ​“​access to medical treatment and 
care, individualized and appropriate to that person, without the [prerequisite] requirement of a 
mental health professional’s evaluation to access medical care.”  Informed consent is already 160
being used in trans healthcare, typically by clinics  in urban settings  such as LGBT health 161 162
clinics or Planned Parenthood, rather than private or solo practices. Timothy Cavanaugh et al. 
advocate for the informed consent model as more “...respectful of the patient’s sense of agency”
 than the gatekeeping model. They argue that transgender patients should have complete 163
autonomy in assessing the type of treatment they would like to pursue.  
The ideological origins of informed consent can be traced back to The Nuremberg Code, 
the result of the Nuremberg trials of Nazi war criminals under international law at the end of 
WWII, which sought to establish an end to physicians and scientists’ experimenting on patients 
without their consent.  Its first principle states that in scientific research, “The voluntary 164
consent of the human subject is absolutely essential.”  Under this principle, the document states 165
160 S. E. Smith, “Does Informed Consent Mean ‘Hormones on Demand’ for Trans People? Not So Much.” ​Rewire 
News.​ Published Jul 10, 2018. 
https://rewire.news/article/2018/07/10/informed-consent-mean-hormones-demand-trans-people-not-much/. 
Accessed April 16, 2019. 
161 In a study by Madeline B. Deutsch, of 12 sites utilizing the informed consent model, only 16.7% were 
solo/private practices. Deutsch, “Use of the Informed Consent Model in the Provision of Cross-Sex Hormone 
Therapy: A Survey of the Practices of Selected Clinics.”  
162 Of 12 sites utilizing the informed consent model, 75% were in urban settings. Ibid. 
163 ​Cavanaugh et al.,“Informed Consent in the Medical Care of Transgender and Gender-Nonconforming Patients.”  
164Shuster,“Performing informed consent in transgender medicine,” 191. 
165 ​The Nuremberg Code.​ Available online at https://www.baruch.cuny.edu/hrpp/documents/nuremburg_code.pdf. 
1947.  
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the patient should, “...have sufficient knowledge and comprehension of the elements of the 
subject matter involved as to enable him to make an understanding and enlightened decision.” 
Informed consent, then, is founded on the principle that a patient must be able to legally consent 
to a given treatment, procedure, or test, and in order to do this must also have “sufficient 
knowledge and comprehension” about the risks and benefits of all available relevant treatments. 
The Nuremberg Code and other subsequent attempts to advance informed consent are all 
intended to increase patient autonomy, “an ideological principle that patients and test subjects 
should have the right to self-determination in health-related matters, and the opportunity to make 
free and informed choices about their bodies, health, and lives.”  166
Informed consent, although it has clear ethical principles, seems to be difficult for doctors 
to follow in practice when it comes to providing treatment to trans patients. Many seem to 
misunderstand what informed consent entails.  One provider who claimed to be using this 167
model said in an interview with sociologist Stef Shuster,  
...you also want to make sure that the person has the capacity to make decisions 
about their lives. And with trans people, that becomes a little tricky because 
sometimes they don’t want to hear about the risks involved in starting hormone 
therapy and how that is going to make their lives difficult.   168
This provider was expressing doubt about the capacity that trans people have to make decisions 
about their care because they have already decided that they want to pursue a particular treatment 
path. But if a person has already dedicated a considerable amount of time to their decision to 
pursue a given treatment, their decision has already been made. This doctor is expressing a desire 
to be more involved in the decision-making process and have control over its outcome, thereby 
rendering “‘autonomy’ a conditional concept” and making it difficult for the trans person to 
166 ​Shuster, “Performing informed consent in transgender medicine.” 
167 ​Ibid. 
168 ​Ibid, 193. 
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make a fully autonomous decision concerning a given treatment.  Additionally, he is separating 169
trans people from all other categories of people with the phrase, “...with trans people, that 
becomes a little tricky…” and participating in the reification of pathologized trans identity in 
which trans people are inherently characterized by their desire to pursue a transition.  
Doctors still utilize their subjective judgment and opinions of their patients under the 
informed consent model in order to withhold access to treatment. Shuster quotes another 
provider, a family physician, who questioned whether or not her new patient, a trans man who 
had been on testosterone for ten years and was seeking a refill, was actually listening to the 
information she provided during the appointment. “I was concerned about what was his level of 
understanding in the consent I was reading to him, and with him? He was nodding along but I 
just wasn’t sure he was really listening.” Ultimately, she denied his request to refill his 
prescription for testosterone. These types of suspicions are grounded in the providers’ subjective 
feelings about whether or not this person is making an appropriate decision to pursue hormone 
therapy or surgery. Another provider expressed concerns that his patients were lying to him:  
If I’m concerned about trans men because their testosterone levels are really high, 
and they’re taking - ​if I believe them - ​regular doses, I’ll take a look….So then I 
wonder if my patient is taking more than he says he is.  170
This providers’ incredibly paternalistic attitude towards his patients effectively squashes his 
patient’s autonomy and reinforces his role as a discerning eye that catches disobedience to 
medical authority and disciplines it by withholding access to treatment. 
In the next chapter, I discuss the various financial barriers to accessing transition-related 
care and how privatization of trans healthcare constructs treatment as a product that is separate 
169 ​Ibid. 
170 Ibid,​ ​194. 
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from the diagnosis of gender dysphoria, and functions to distribute access to this product on the 
basis of ability to pay. 
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Chapter 3 
  
The Politics of Coverage: Privatization, Health Insurance, and Medical Necessity 
 
In the American market economy, the quest for self-expression increasingly 
involved the purchase of goods and services that promised a better life. For the 
American transsexual, surgery was such a commodity, a desperately desired 
consumer item, available only to those who could afford it.   171
 
Desire, sex, and gender resemble neither the earth nor manufactured products. 
Desire, sex, and gender are,in reality, closer to information as an embodied 
technosemiotic system. They are living codes. Like information, they defy 
ownership because my possession of a fragment (of information, desire, pleasure, 
sex, gender) doesn’t take it away from you.  172
 
 
Accessing transition-related services in the U.S. has always been a matter of whether or 
not one is able to afford them; after all, medical care in the U.S. has the highest price tag of any 
country in the world.  By the early 1980s, doctors in the private sphere realized that providing 173
‘treatment’ for trans people, particularly surgical treatment, was extremely profitable. With the 
standards of care to guide and legitimate their work, private practitioners began offering 
counseling, hormones, and surgery for trans populations nationwide. The ‘treatment’ for 
transsexualism thus because a commodity to be purchased on the free market that was separated 
from the diagnosis. 
The raising prices of transition-related care functioned to render these services virtually 
inaccessible to those who could not afford to pay out of pocket or are uninsured. Privatization of 
171 Meyerowitz, ​How Sex Changed​, 141. 
172 ​Paul B. Preciado, ​Testo Junkie: Sex, Drugs, and Biopolitics in the Pharmacopornographic Era​. Feminist Press. 
2013. 277. 
173 ​Jessica Glenza, “Sky-high prices of everything make US healthcare the world’s most expensive,” ​The Guardian​. 
Published March 13, 2018. 
https://www.theguardian.com/us-news/2018/mar/13/us-healthcare-costs-causes-drug-prices-salaries. Accessed 
March 25, 2019.  
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trans healthcare in a country that does not provide basic universal health insurance coverage 
unevenly distributes life chances across populations, leaving low-income trans people with few 
options to access care. It is not surprising, then, that health insurance is one of the main deciding 
factors in determining access to hormones and surgery. First, there is the issue that trans people 
are disproportionately uninsured, primarily as a result of employment discrimination, rendering 
transition-related care all but inaccessible through mainstream medical channels. Second, even 
when trans people do have health insurance, it operates as a regulatory mechanism that defines 
what constitutes medically necessary treatment for gender dysphoria, and, in the process, 
actually constructs gendered bodies. In what ways did privatization transform the availability of 
treatment, and why? How do the politics of health insurance coverage construct medically 
necessary treatments? What are the consequences of separating the diagnosis ‘gender dysphoria’ 
from the treatment? Why, to this day, are insurers so reluctant to offer coverage for 
transition-related medical care? 
 
Health Insurance 
During the age of university-based gender identity clinics, which charged roughly $1,600 
total for psychological evaluations, surgery, and hospital care, public and private health 
insurance  provided spontaneous and sporadic coverage for transition-related care, especially 174
towards the mid to late 1970s.  As these clinics closed, the 1979 Meyer/Reter study  brought 175 176
174 Christine Jorgensen, ​A Personal Autobiography​, 295. 
175 ​Sr. Mary Elizabeth, ​Legal Aspects of Transsexualism​. International Foundation for Gender Education. 1990. 31. 
176 John K. Meyer and Donna J. Reter, “Sex Reassignment: Follow-up” in ​Archives of General Psychiatry​. ​The 
Journal of the American Medical Association, Vol. 36, Issue. 9​, 1010-1015. 1979. 
doi:10.1001/archpsyc.1979.01780090096010.  
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about a wave of federally-funded research  aimed at proving the ineffectiveness of hormonal 177
and surgical interventions as treatments for ‘transsexualism,’ which private insurance companies 
used as a justification not to cover surgery.  Following this study, a strange alliance formed 178
between the Reagan administration, trans exclusionary radical feminists, and conservative 
doctors to push policy that would deny coverage for “sex reassignment,” a practice that was 
facing mounting pushback from both the left and right by this time.  In 1981, the National 179
Center for Healthcare Technology (NCHT), a federally-funded agency that advised the 
Department of Health and Human Services on scientific evidence, colluded with anti-trans 
feminist Janice Raymond,  to release a scientific report recommending that ‘transsexual 180
surgery’ be excluded from coverage under federally-funded plans.  Following the NCHCT 181
report, many public and private insurance plans began explicitly excluding ‘transsexual surgery’ 
from coverage on the grounds that it was “experimental”. The report concludes:  
There is a lack of well controlled, long-term studies of the safety and 
effectiveness of the surgical procedures and attendant therapies for 
transsexualism. There is evidence of a high rate of serious complications of these 
surgical procedures. The safety and effectiveness of transsexual surgery as a 
treatment of transsexualism is not proven and is questioned. Therefore, 
transsexual surgery must be considered still experimental.   182
Many things are happening within this statement that ultimately create a separation between the 
pathologized transsexual condition and its treatment. First, there is a very questionable 
177 ​Sr. Mary Elizabeth, ​Legal Aspects of Transsexualism​, 32-33. 
178 ​Ibid, 31. 
179 ​Stryker, ​Transgender History,​ 140. 
180 ​Raymond is a lesbian feminist who has equated the practice of transsexuality with rape, the patriarchal 
oppression of women, and nazism. She advocated for limiting access to transition-related care whenever possible 
and treating transsexualism with gender reorientation therapy. For more on Raymond, see Stryker, ​Transgender 
History,​ 132-138, and Meyerowitz, ​How Sex Changed, ​260-265. 
181 ​Sr. Mary Elizabeth, ​Legal Aspects of Transsexualism​, 32. 
182 Decision No. 2576; NCD 140.3; Transsexual Surgery. Department of Health and Human Services Departmental 
Appeals Board, Appellate Division. May 30, 2014. 
https://www.hhs.gov/sites/default/files/static/dab/decisions/board-decisions/2014/dab2576.pdf. Accessed April 30, 
2019. 
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preoccupation with the ‘safety’ of trans people who undergo these procedures, implying that they 
care about the safety of trans people who undergo treatment, while at the same time not 
recognizing the reality that many trans people undergo medical transitions partially in order to 
ensure against violence and discrimination. Further, many studies had in fact shown that these 
procedures had very low rates of complications. Second, how can we measure the 
“effectiveness” of these procedures? In the same way that the 1979 Meyer/Reter study measured 
the successful adjustment of post-op trans people by how much their lives conformed to 
heterosexist, classist, and racist ideologies? By concluding that “transsexual surgery” was not in 
fact an effective treatment for “transsexualism,” this NCHCT report left trans people 
simultaneously pathologized and without a claim to the procedures that they desired. 
The 1980s brought about a world of care in which trans people were faced with, as Dean 
Spade describes it, a “double bind,”  simultaneously medicalized while their medical care was 183
excluded from coverage. By 1989, Health and Human Services (HHS) issued National Coverage 
Determination (NCD) 140.3 explicitly excluding ‘transsexual surgery’ as a treatment for 
‘transsexualism’ from coverage under Medicaid on the ground that it was experimental and 
therefore not medically necessary.  Unable to afford the treatment for their condition, many 184
trans people were and still are indefinitely prevented from accessing the status of ‘good’ 
transsexuals, the only version intelligible as deserving of sympathy, forever trapped in a state of 
unaccepted gender variance that is subjected to constant discipline, control, and punishment. 
Trans people was thus established as a condition for which treatment would be inaccessible to all 
183 Dean Spade, “Medicaid Policy & Gender-Confirming Healthcare for Trans People: An Interview with 
Advocates,” in ​Seattle Journal for Social Justice: Transgender Issues and the Law, Vol. 8, no. 2​, 497-514. 2010. 
502. 
184 See footnote 12. 
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except those who could afford it, putting all those who could not in a permanent state of limbo, 
weighed down by the financial realities that prevented them from accessing the embodiment they 
desired.  
 
Private Industry Capitalizes on ‘Transsexual Surgery’ 
As discussed in a previous chapter, by 1980, trans healthcare was transferred out of the 
university clinic setting into the hands of private practices that mainstreamed the use of the 
HBIGDA standards of care. Take, for example, Dr. Stanley Biber, who turned his hometown of 
Trinidad, Colorado into the “Sex Change Capital of the World” by the mid 1980s, operating 
primarily at San Rafael Hospital.  His practice, as detailed in a letter to famous gay trans man 185
and activist Lou Sullivan, followed the standards of care for all patients who sought surgery. 
Biber writes,  
We require that you have lived, worked and dressed in the male role for a period 
of at least one year. We must have a psychiatric evaluation plus we must have one 
additional single evaluation either by another psychiatrist or a psychologist.  186
As this quote exemplifies, Biber and other private surgeons enforced the use of the standards of 
care in the world of private practices. Meyerowitz argues that this was largely performative 
professionalism to advance their financial interests: “If they adhered to these guidelines, private 
practitioners could protect their professional standing and distinguish themselves from ‘chop 
shop’ doctors…”  Maintaining professional standing was in the best financial interests of these 187
doctors, who charged $6,225 a pop for vaginoplasty, $3,650 for double mastectomy, and as 
185 S.J. Guffey, “Colorado town is sex-change world capital,” ​New Orleans Times-Picayune​. Published Jan 27, 1985. 
Transas City. 
http://transascity.org/files/news/1985_01_27_New_Orleans_Times-Picayune_B2. Accessed April 29, 2019. 
186 ​Correspondence from Stanley Biber to Lou Sullivan, Feb 3, 1986. 
https://www.digitaltransgenderarchive.net/files/sj139204g. Accessed April 29, 2019. 
187 ​Meyerowitz, ​How Sex Changed,​ 273. 
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much as $14,300 for phalloplasty. With doctors such as Biber performing up to 100 such 
surgeries every year (with vaginoplasty being by far the most common procedure),  upholding 188
professional standards allowed them to charge high fees and make the most profit. One trans 
woman Biber operated on recalled her reasons for choosing this particular doctor, “Dr. Biber has 
a very good record,” she continues, “If I’m going to take the step, I want the best.”  189
Transition-related medical care thus became a highly sought after and expensive commodity with 
a niche consumer base that bolstered its claims to legitimacy. Having the kind of patients that 
can afford to pay out of pocket for your treatments constructs these doctors as especially sought 
after and offering the best standard of care, key marketing tactics meant to sell their product. 
Though the standards of care provided the illusion of objectivity, doctors’ subjective 
decision-making often overrode formal criteria and took precedence over all else. Dr. Biber was 
concerned about misdiagnosing his patients, fearful that they might actually be schizophrenics, 
extremely feminine homosexuals, or transvestites, rather than true transsexuals.  In order to 190
avoid this, he enforced the standards of care for every patient that came in requesting surgery as 
a preliminary sorting method. However, as a 1985 New-Orleans Picayune article describes, 
“Even after that, Biber goes by his gut feeling and some get turned away.” His gut feeling is 
anchored in his years of professional experience: he remarks, “I’ve seen so many that I can 
almost count on my gut feeling when they walk through the door.”  Ultimately, the decision of 191
whether or not to grant access to care depended on whether Dr. Biber had a bad feeling in his gut 
about a certain patient the moment they walked through the door and he was able to scan their 
188 ​ S.J. Guffey, “Colorado town is sex-change world capital.”  
189 Ibid. 
190 ​Ibid. 
191 ​Ibid. 
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appearance and mannerisms for the gendered embodiments he was looking for. As Paul Preciado 
writes, “The unveiling of gender depends on an optical ontology: the real is what you can see.”  192
Gut feelings, as most people understand, are not grounded in scientific knowledge, professional 
standards, or expertise: they are the product of personal beliefs, opinions, and prejudices. What 
does a true transsexual ‘look’ like, in Dr. Biber’s objective opinion? What do they act like, walk 
like, sound like? 
In order to maximize profits from transition-related medical care, doctors often required 
cash payments up-front to avoid dealing with the unwillingness of health insurance to cover 
these procedures. Public insurance, such as Medicare and Medicaid, ruled in 1981 that ‘sex 
reassignment’ was cosmetic, elective, and experimental, and thus was to be excluded from 
coverage. Most private insurance companies during this time refused to provide coverage for 
transition-related surgeries, and even the ones who did provide it were  “inconsistent and at times 
arbitrary.”  Dr. Biber remarked in 1989, “...general insurers are giving us a really hard time and 193
are giving our patients a hard time too.”  Transition-related care, embodied in the form of sex 194
and gender, is thus constructed as a marketable, tangible product that consumers would go to 
great lengths to pay for, even in the absence of assistance from health insurance. To become a 
man or woman, one must “buy” a sex change in order to satisfy this desire. This creates a 
scenario in which only trans people who could afford high out-of-pocket prices were able to 
192 ​Preciado, ​Testo Junkie: Sex, Drugs, and Biopolitics in the Pharmacopornographic Era​, 102. 
193 MTF activist Dallas Denny wrote in 1994, “…insurers are very inconsistent and arbitrary, paying in some states 
but not others, in some years but not others, and for some persons but not others.” Dallas Denny, ​Identity 
Management in Transsexualism: A Practical Guide to Managing Identity on Paper​. Creative Design Services. 1994. 
56.  
194 Wendy Pierce, "An Interview with Dr. Stanley H. Biber” in ​Twenty Minutes: Anniversary Issue​, 5-7. The XX 
Club. October 1989. Digital Transgender Archive. https://www.digitaltransgenderarchive.net/files/d791sg26z. April 
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access quality surgical interventions from reputable doctors like Dr. Biber, and all others will 
either have to do without or obtain through illicit channels. 
In the next section, I discuss the contemporary landscape of health insurance exclusion 
for trans people in the U.S., and how the privatization of trans healthcare laid the groundwork for 
a reality in which low-income, Black and Latinx trans people are barred from accessing such 
services. 
 
Health Insurance and the Distribution of Life Chances  
Health insurance, as with all forms of insurance, is a “technology of risk”  that allows 195
us to have a sense of security about future uncertainties that might result in loss or harm to our 
bodies and possessions. In order to acquire health insurance, one must be able to pay monthly 
premiums in order to prepare for unspecified future risk. Colombia professor Geeta Patel argues 
that people often form social or political groups based on the risks they face as a group.  Trans 196
people, in addition to the risks of violence, death, and unemployment, face the risk of not being 
able to access the embodiment in which they imagine themselves living happy and fulfilling 
lives.  Many health insurance plans, it seems, are generally unwilling to insure against this risk 197
and provide trans people with a measure of security against the uncertainty this arouses within us 
and the dangers it subjects us to. Trans people who are unable to buy into an investment against 
195 Geeta Patel, “Imagining risk, care and security: Insurance and fantasy” in ​Anthropological Theory, Vol. 7, no. 1​, 
99-118. Sage. https://journals.sagepub.com/doi/pdf/10.1177/1463499607074297. 2007. 99. 
196 ​Patel, “Imagining risk, care and security: Insurance and fantasy,” 109. 
197 “‘Being at risk’: a phrase that is familiar to people who live in the USA and who engage with issues around race, 
disability or sexuality. Being at risk: for losing one’s life if one is a young black or Native American Man, for losing 
one’s rights to healthcare if one works for a corporation that is downsizing. Women of color become bonded to each 
other, stand surety for each other perhaps, because they are at risk for not getting access to the kind of life that is 
made through the labor of producing a good life--whether that is via education or a job or access to a breast 
examination or welfare or to medication for HIV.” Geeta Patel, “Imagining risk, care and security: Insurance and 
fantasy,” 109. 
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future risk are faced with extreme levels of uncertainty unaided. “For someone who is financially 
strapped, money that might go unnoticed, automatically subtracted from a paycheck to provision 
insurance policies, pension funds or social security, is money that becomes extraordinarily 
visible.”  In the U.S., access to health insurance typically falls along the lines of race and class: 198
this is also true of the trans population. Of the 14%  of trans people who reported being 199
uninsured in the 2015 US Transgender Survey, the sub-populations with the highest rates of 
being uninsured were Black (20%), American Indian (18%), and Latino/a (17%).  Left to face 200
the uncertainty of being a living person with a body and no health insurance, these populations 
are faced with little to no feeling of security in their futures, and at any moment something could 
happen with their health that they would not be able to afford treatment for out of pocket. For 
these populations, in the absence of health insurance, they are subjected to power that functions 
to “distribute life chances across populations,” a kind of power Dean Spade calls “population 
management.”   201
One of the most striking features of the aforementioned “double-bind”  is that trans 202
people are often trapped in a cycle, unable to afford the treatment (particularly hormones, laser 
hair removal, and face feminization) that they need to find suitable employment with sustainable 
wages. Most of the general U.S. population (56% in 2015)  accesses health insurance through 203
employers, with the remainder having some form of public insurance or being uninsured. Trans 
198 ​Patel, “Imagining risk, care and security: Insurance and fantasy,” 100. 
199 Compared to 11% in the general population. James, S. E., Herman, J. L., Rankin, S., Keisling, M., Mottet, L., & 
Anafi, M. ​The Report of the 2015 U.S. Transgender Survey​. Washington, DC: ​National Center for Transgender 
Equality.​ 2016. 94. 
200 ​Ibid, 94. 
201 ​Dean Spade, Normal Life: Administrative Violence, Critical Trans Politics, and the Limits of Law. South End 
Press. 2011. 110.  
202 ​Spade, “Medicaid Policy & Gender-Confirming Healthcare for Trans People: An Interview with Advocates,” 
501. 
203 ​Herman et al., ​The Report of the 2015 U.S. Transgender Survey, ​94. 
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people often have a hard time finding jobs, receiving promotions,  and maintaining jobs,  not 204 205
least because many states require medical documentation showing proof that a trans person has 
undergone surgery in order to change a gender marker on their ID.  Consider Santos Arce, a 206
49-year-old Latino trans man, who reflected in an interview about having a hard time finding 
work prior to transitioning medically: “...showing up as a young butch to a job interview and 
giving those signals, you’re often not going to get the job as a secretary.”  The inability to 207
access the very thing that they need to afford to pay out of pocket for transition-related care thus 
leaves many trans people, particularly Black trans people, trapped in a state of constant deferral. 
Some engage in criminalized sex work or drug dealing in order to pay for medical care from 
illicit sources, further subjecting them to violence, incarceration, and risk from unmonitored 
hormone use or botched surgeries.  208
Excluded and Denied 
The landscape of coverage has changed significantly since the the 1980s and 1990s, with 
more and more plans offering coverage for transition-related care based on the mounting medical 
and legal consensus that it is medically necessary, including Medicaid and Medicare.  Starting 209
in 2005 with California, a new wave of state legislation increasingly banned health insurance 
discrimination against clients based on their gender identity or expression--meaning, if a plan 
covers treatments for other medical conditions, such as a double mastectomy as a treatment for 
204 ​2015 U.S. Transgender Survey​, 151. 
205  ​Ibid, 149. 
206 ​ Spade, “Medicaid Policy & Gender-Confirming Healthcare for Trans People,” 499. 
207 ​Santos Arce Interviewed by Lorenzo Van Ness. ​New York City Trans Oral History Project.​ Date of Interview 
July 14, 2017. http://oralhistory.nypl.org/interviews/santos-arce-nx3hjo#55:30. Accessed April 30, 2019. 
208 Spade, “Medicaid Policy & Gender-Confirming Healthcare for Trans People,” 499. 
209 Keren Landman, “Fresh Challenges To State Exclusions On Transgender Health Coverage,” ​NPR​. Published 
March 2, 2019. 
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breast cancer, then they must cover those same treatments for gender dysphoria. Currently, 21 
states and Washington D.C. have laws banning blanket trans exclusion clauses by private 
insurance companies.   With healthcare discrimination based on gender identity being legal in 210
29 states,  many trans people routinely  experience denial of coverage for claims related to 211 212
transition-related care: 55% of trans people reported having a claim for surgery denied, and 25% 
reported being denied coverage for hormone therapy.  Take, for example, Arkansas BlueCross 213
BlueShield’s policy as of January 2017. It reads, “Coverage eligibility of Gender Reassignment 
Surgery for Gender Dysphoria is a contract-specific benefit issue. When benefits for gender 
reassignment surgery are available, coverage may vary and under some plans may be excluded.​”
 ​Because private plans are not legally required to cover the care in Arkansas,  largely, the 214 215
decision about whether or not to provide coverage rests with employers, who can choose plans 
that cover the services or not. In more conservative states such as Arkansas, Mississippi, and 
Alabama, increased levels of religiosity and social conservatism animate the majority of the 
pushback against offering coverage for transition-related healthcare.   216
Medical Necessity 
The logic of denying coverage is grounded in the notion of “medical necessity,” which 
political theorist Daniel Skinner notes “serves as the primary gatekeeper for the utilization of 
210 See ​http://www.lgbtmap.org/equality-maps/healthcare_laws_and_policies​.  
211 ​2015 U.S. Transgender Survey. 
212 13% report denial of coverage for claims related to transition-related care occurs frequently. Ibid. 
213 Ibid,​ ​95.  
214 ​Gender Reassignment Surgery for Gender Dysphoria. Arkansas BlueCross Blue Shield. Last updated October 
2018. ​https://www.arkansasbluecross.com/members/report.aspx?policyNumber=2016024​. Accessed April 30, 2019. 
215 ​See footnote 40. 
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health care services.”  The concept is used by health insurance plans in order to differentiate 217
between necessary and unnecessary medical care through defining the boundaries of medical 
care and cosmetic, elective, or experimental procedures, “in the name of ensuring that patients 
receive treatment that is appropriate and medically indicated while also controlling costs.”  218
This division between necessary and unnecessary medical care brings us into murky moral 
territory. What are medically necessary procedures are necessary for bodies to undergo? What 
does it mean to say that the same procedures are necessary for certain bodies but not trans 
bodies? Medical treatments for less politically charged pathologies, such as insulin for type I 
diabetes, are administered with the goal of achieving a certain result that is related to the 
condition, like maintaining healthy blood sugar levels to prevent complications and/or death--in 
essence, to sustain life. Treating gender dysphoria with hormone therapy and/or surgery does not 
necessarily directly prevent death in the same way, although it has been shown to improve 
psychological outcomes.  Instead, the goal of such a treatment, at least for the trans person, is to 219
enhance quality of life and achieve their desired embodiment. When insurance plans argue that 
these treatments are not medically necessary, they are also arguing that enhancing the quality of 
life in this population is not urgent or necessary. Transition-related surgeries are thus 
categorically defined by insurers that exclude them from coverage as being in the realm of the 
cosmetic or elective, and therefore, not urgent for the person seeking them. 
217 ​Daniel Skinner, “Medical Necessity under the Patient Protection and Affordable Care Act” in ​Public 
Administration Review, Vol. 73, The Health Care-Crucible Post-Reform: Challenges for Public Administration​, 
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The Food and Drug Administration (FDA) has not, as of yet, approved hormones as 
medications to be used in the treatment of gender dysphoria, despite the fact that numerous 
professional associations, including the APA, AMA, and WPATH, have released statements 
approving these treatments as “medically necessary,”  and therefore, not experimental. When 220
insurance companies deny coverage for hormone therapy on the grounds that it is experimental, 
they point to the lack of approval from the FDA for these medications as treatments for gender 
dysphoria. One nurse remarked to sociologist Stef Shuster, “You have to realize contextually this 
is ​weird medicine​. We’re using non-FDA approved drugs, in non-FDA approved ways.”  221
Maintaining the idea that hormone therapy is somehow strange, weird, and experimental affects 
trans people twofold, simultaneously stigmatizing the care that they seek and justifying 
arguments in favor of withholding coverage.  
Further, procedures and treatments that many trans people desire and seek out are 
explicitly excluded on the grounds that they are ‘cosmetic’ by providers that do actually offer 
coverage for hormones and/or surgery as treatments for gender dysphoria. In so doing, providers 
are participating in the construction of gendered bodies. For example, Aetna excludes the 
following procedures, among many others, from coverage as treatments for gender dysphoria on 
the grounds that they are cosmetic: voice modification surgery, body contouring, hair removal, 
and facial masculinization or feminization.  By only offering coverage for hormone therapy, 222
220 ​Ibid, 253. 
221 ​Shuster, “Performing informed consent in transgender medicine,” 194. Emphasis added. 
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chest/breast surgery, and/or genital surgery, Aetna is participating in constructing what elements 
of the body are most essential to alter for trans people to achieve successful embodiment as men 
or women, thereby reducing gender to chest, genitals, and blood levels of testosterone or 
estrogen. However, as trans political historian Paul Preciado argues,  
...the beard and the voice, and not the penis and the vagina or X and Y 
chromosomes, are the dominant cultural public signifiers of gender in our society. 
Let us cease to speak about men and women and simply say hairy body or smooth 
body, body with a high voice or with a low voice.  223
For transfeminine people who undergo estrogen therapy, the timbre of their voice does not 
change as it does for transmasculine people taking testosterone. Similarly, estrogen does not alter 
the presence of existing facial or body hair. Dean Spade writes, “For surviving daily life--work, 
school, street interactions--these external markers of gender are far more important than genital 
appearance, which is usually only known to one’s closest intimates.”  Through denying 224
coverage for hair removal or voice therapy/surgery as treatments for gender dysphoria on the 
grounds that they are cosmetic, insurance plans construct these things as inessential to realizing 
embodied gender, that is, a vagina makes a woman, not a hairless face or a soft voice. In doing 
so, they simultaneously construct themselves as experts on what constitutes gender and gender 
itself. 
As discussed in a previous chapter, the WPATH standards of care and the DSM-5 gender 
dysphoria diagnosis function as gatekeeping mechanisms that ration out care to trans people. 
These gatekeeping mechanisms have become embedded within the language of many insurance 
plans; Schulz writes, “[t]he Standards of Care...have also been institutionalized at the policy 
level by managed-care insurance companies and court systems.”  Ilhan, a trans man living in 225
223 Preciado, ​Testo Junkie: Sex, Drugs, and Biopolitics in the Pharmacopornographic Era ​, 227. 
224 Spade, “Medicaid Policy & Gender-Confirming Healthcare for Trans People,” 499. 
225 ​Schulz, “The Informed Consent Model of Transgender Care,” 75. 
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New York City, reflects on gatekeeping from his health insurance, which he has through a 
unionized job:  
I’m still definitely going to be covered, which is great. The only issue is that to 
qualify for these procedures I need to jump through a lot of hoops. I need to have 
two letters from mental health providers...one of them is supposed to have a 
specialty in gender therapy, which is really hard to find someone who has 
explicitly a speciality in that. I also have to get a letter from a physical healthcare 
specialist…  226
Despite the New York law mandating that insurance providers cover transition-related medical 
care, trans people like Ilhan, who has already had top surgery and been on hormones for quite 
some time, still constantly face barriers to accessing care. He continues, “[t]he really hard thing 
has been dealing with the mental health stuff…”  Many insurance plans, as per WPATH 227
guidelines, require a mental health professional to sign off that they meet the requirements for 
gender dysphoria prior to accessing care. Schulz writes,  
...mental health practitioners...may not feel comfortable granting access to health 
services outside of the context of a longer term therapeutic relationship. 
Therefore, the length of therapy may range from a few sessions to months in 
therapy, and this length depends largely on how long the mental health 
practitioner deems it necessary for the client to attend therapy, not necessarily the 
client’s therapeutic goals.  228
Trans people like Ilhan are thus in a situation where their ability to even get diagnosed in order to 
access the care is complicated by financial constraints. They might be able to afford a small 
monthly co-payment for hormones, but not the higher co-pays for counseling sessions with 
licensed therapists that could potentially extend for months. Many trans people might not be able 
to take time off from their lives in order to travel to and from a therapist and attend a 50-minute 
counseling session.  
226 Ilhan N. Interviewed by Tyler M. Date of Interview August 25, 2018. ​New York City Trans Oral History Project​. 
http://oralhistory.nypl.org/interviews/ilan-n-ku0e9m. Accessed April 30, 2019. 
227 ​Ibid. 
228 ​Schulz, “The Informed Consent Model,” 81. 
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When coverage for hormone therapy and surgery is denied on the basis that it is not 
medically necessary, it is brought into the realm of an individual responsibility, one that the trans 
person must bear the financial burden of alone. David Goldhill, writing for the Atlantic, reflects 
on arguments related to medical necessity by using the example of the statin he takes for his high 
cholesterol.  
It's worth thinking about my personal decision for a moment. When I chose a 
statin, society subsidized that choice at the point of purchase through the tax 
advantages afforded insurance and my health saving account. If I were a Medicare 
or Medicaid beneficiary, society's subsidy would have been more direct. Since we 
all ultimately pay for these subsidies, we should all care about the choices our 
policies encourage.  229
In Goldhill’s words, we get to the heart of why Americans care so much about whether or not 
health insurance plans provide coverage for transition-related medical care. By framing the 
‘choice’ to pursue a certain medical procedure or treatment as an individual choice, he invokes 
narratives that are very salient in U.S. culture about personal financial responsibility. Since 
taxpayers are subsidizing our healthcare, whether indirectly or directly, society should get to 
decide what is covered and what is not, and treatments that should not be covered are those 
treatments which are cosmetic or elective, or a matter of individual choice. Taxpayers, he 
reasons, should not have to take financial responsibility for the individual choices of people who 
refuse to play their part by paying their individual financial responsibilities.  
One might think that the answer lies in an attempt on the part of health insurance 
companies to cut costs across the board by minimizing the number of procedures they cover 
irrespective of the diagnosis or the person seeking them. However, this does not seem to be the 
229 David Goldhill, “Who Defines ‘Medical Necessity’?” ​The Atlantic​. Published January 8, 2014. 
https://www.theatlantic.com/health/archive/2014/01/who-defines-medical-necessity/282500/. Accessed April 30, 
2019. 
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case: a 2008 study showed that a total annual cost of as little as 17.3¢ per resident and 6.6¢ to 
employers would be added if health insurance plans provided coverage for transition-related 
care.  Similarly, a complaint filed by a student at University of Wisconsin School of Medicine 230
in 2016 over denial of coverage for her gender confirmation surgery noted that state consultants 
estimate the total yearly cost for covering such procedures for all trans people on public 
insurance in Wisconsin would range between $100,000-$250,000, “less than two-tenths of 1 
percent of the health program budget at most.”  Trans people are a relatively small population, 231
and so few actually choose to pursue surgical care or hormone therapy in a given year. Providing 
coverage for these services, it has been argued, may act as a form preventative care for trans 
people, who often experience symptoms associated with having an unmet need for care, such as 
anxiety, depression, and suicidality,  thereby proving more cost-effective in the long-run for 232
everyone involved.  
What is the reason, then, that insurance providers continue to argue in favor of denying 
coverage for transition-related care? Dean Spade argues that the power of the major societal 
institutions such as education, medicine, insurance, functions not necessarily through 
“prohibition or permission but rather through the arrangement and distribution of security and 
insecurity.”  Through denying coverage for transition-related care, insurance companies 233
produce insecure conditions for trans people in their day-to-day lives, leaving them unable to get 
accurate IDs, unable to find jobs, and without safe access to the care they are seeking. Spade 
230 Mary Ann Horton,​ Cost of Transgender Health Benefits, Out & Equal Workplace Summit​.​ ​September 2008. 
http://www.tgender.net/taw/thbcost.html#thbcost.​ ​Accessed March 31, 2019. 1. 
231 ​Samantha Allen, “Wisconsin Pulls Plug on Trans Health Care,” ​The Daily Beast​, February 7, 2017, as quoted by 
Dana Holle in “Health is Health: Section 1557 of the Affordable Care Act and Transgender Healthcare Rights in 
Wisconsin and the United States,” 255. 
232 ​Spade, “Medicaid Policy & Gender-Confirming Healthcare for Trans People.” 
233 ​Spade, ​Normal Life, ​110. 
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writes, “Because they are marginalized in employment, and may feel that such healthcare is 
urgent, many transgender people engage in criminalized activities such as sex work in order to 
raise money to purchase hormones from informal sources.”  Black trans woman Kristen P. 234
Lovell recounted her experiences as a sex worker in the late 1990s on Christopher street, 
including accessing street hormones. She remembers,  
We used to go down to Chi-Chi’s to get it. There was a person at the door, you 
would give them some coin, they would take a list and then they would come 
back with the Premarin pills, you’d come back in the next few days to see if your 
“prescription” was ready. 
While Kristen was forced into a position where she had to rely on street hormones she funded 
through sex work, this can cause a whole host of problems, particularly health-related, as using 
these medications without medical supervision can result in HIV, hepatitis, organ failure, and/or 
nerve damage, among other conditions that result from unsupervised injections and unsanitary 
needles.  Black, Latinx, and low-income trans people are disproportionately exposed to these 235
risks. 
 
Limits of the Non-Discrimination Approach to Trans Exclusionary HealthCare 
What the future bodes for legislation on health insurance coverage of transition-related 
care is uncertain at the moment, but it is not a steady march towards inclusion. Many have 
argued for fighting for coverage at a state or local-level through using non-discrimination law.  236
234 ​Spade, “Medicaid Policy,” 499. 
235 Ibid. 
236 “We do not think that a federal legislative strategy would be helpful at this time. We think that 
locally-based strategies will be most effective and that people in those communities are best situated to 
evaluate whether litigation, legislative, regulatory, or other approaches will be most effective in their 
state. Community organizing can also be important in this work and community accountability is always 
vital.” Dean Spade. “Medicaid Policy & Gender-Confirming Healthcare for Trans People: An Interview 
with Advocates” in Seattle Journal for Social Justice, Vol 8. Issue 2. 2010. p. 508. 
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At the state level, where the vast majority of decisions about healthcare policy are made, there is 
a positive trend towards outlawing discriminatory health insurance policies, but in many states 
employers are still free to purchase plans that exclude or deny coverage for transition-related 
care. The federal situation is also complex: section 1557 of the Affordable Care Act, passed in 
2010, banned any plan that received federal funds from discriminating on the basis of sex, which 
has been interpreted as covering discrimination on the basis of gender identity. Section 1557 
does not require insurers to provide coverage for any particular treatments commonly used for 
gender dysphoria. Non-discrimination law seeks to eliminate explicit discrimination from 
insurance providers on the basis of diagnosis, rather than targeting the systemic barriers to 
accessing healthcare faced by trans people. As previous sections of this chapter have already 
argued, even when plans provide coverage there are still major systemic barriers to access built 
into health insurance plans. The Trump administration is currently making moves to overturn the 
ACA. In late 2018 conservative Texas federal district judge Reed O’Connor requested and was 
granted a nationwide prohibition on the enforcement of the rule. HHS is expected to reverse the 
regulation on Section 1557 to “​redefine discrimination “on the basis of sex” to eliminate 
protections based on gender identity and termination of pregnancy.”   237
Moving forward, activists and lawyers need to focus on eliminating the intersecting 
vectors of oppression that cause systemic barriers for trans people accessing care. There should 
be a focus on uniform recognition of transition-related care as medically necessary, as well as 
expanding access to health insurance coverage through adoption of a universal single-payer 
healthcare system. A non-discrimination approach does little to protect trans people who have no 
237 Katie Keith, “More Courts Rule On Section 1557 As HHS Reconsiders Regulation,” ​Health Affairs​. 
https://www.healthaffairs.org/do/10.1377/hblog20181002.142178/full/. Published October 2, 2018. Accessed March 
26, 2019. 
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health insurance in the first place. Already in the preliminary campaigning for the 2020 election, 
many candidates are pushing for universal single-payer healthcare. It is likely that the U.S. will 
have to grapple with the growing demand for a new healthcare system in the coming years.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
73 
Conclusion: Demedicalizing Transitions 
 
Is it possible to imagine a different reality in which transition-related care is free and easy 
to access? Or, better yet, where gender variance is not pathologized? Many trans authors and 
activists have taken part in dreaming that pathologization, gatekeeping, and insurance denial are 
things of the past, or, better yet, never existed in the first place. What would a trans subjectivity 
look and feel like in this context? Feminist trans scholar Sandy Stone, who catalyzed a wave of 
trans theory and scholarship with her 1987 ​Posttranssexual Manifesto​, writes, 
The highest purpose of the transsexual is to erase h/erself, to face into the 
‘normal’ population as soon as possible. Part of this process is known as 
constructing a plausible history--learning to lie effectively about one’s past. What 
is gained is acceptibility in society. What is lost is the ability to authentically 
represent the complexities and ambiguities of lived experience...  238
Trans people who cannot access the material embodied existence that they desire are 
hypervisible. For those who can, narratives and lives are erased and subsumed by a narrative of 
distress and self-hatred that seeks to erase any semblance of gender variance. Stone then asks, 
“How, then, can the transsexual speak? If the transsexual were to speak, what would s/he say?”  239
How can we move outside of the pathologized position that has been carved out for us, and 
imagine our own futures in ways that are not bound to oppressive and binary gender systems 
rooted in racism?  
Katherine Collins, a trans woman writing in 1994, reflects on the immense gravitational 
pull that the desire for surgery has had in her life, bringing with it the sense of “walking toward a 
brilliantly lit altar.”  Once she actually undergoes the procedure, however, reality fell short of 240
238 ​Sandy Stone, ​The Empire Strikes Back: A Posttranssexual Manifesto. ​Published 1987. 
https://sandystone.com/empire-strikes-back.pdf. Accessed April 30, 2019. 
239 ​Ibid.  
240 ​Katherine Collins. "Silent and Transfixed in the Transsexual Factory” in ​Transsexual News Telegraph​, Spring 
1996. 26. 
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her expectations. “...the result of this assembly-line process is that the initial spiritual impact of 
the event is completely nullified. One arrives here with a certain defensiveness, bearing her 
letters, hard-won from a suspicious and begrudging world, and one almost expects to be turned 
away at the last minute on some technicality.”  Trans people are cheated from the potentially 241
amazing experience of surgically altering your body to reflect the way you see yourself thriving 
in the word. Medicalizing this process has completely removed the possibility that it might be 
enjoyable and even fun for the person who undergoes it. Profoundly, Collins asks, “...what might 
it be like, how much better for all concerned--for all society--if SRS and all medical procedures 
were accompanied by an air of spirituality?” 
Can we imagine the potential of a demedicalized experience of transition, one that is 
democratized and made safe and available to all those who seek to disrupt their gendered 
embodiment? She continues,  
To take the transsexual process out of the realm of strictly medical, and into the 
spiritual realm, would be to entirely eliminate the adversarial obstacle-course that 
many transsexuals encounter. To make it a question not of who is crazy and who 
is not, and instead to invest it with a series of spiritual counselings, investigations, 
and ceremonies, would lead the final SRS initiate to the moment of ritual “blood 
sacrifice” with a sense of deep awe and wonder and privilege and responsibility. 
What possibilities exist for claiming ownership over this process and reasserting our claims to 
our bodies? So many possibilities, both in terms of the experiential and the multiplication of 
bodies that do not claim one gender or the other. Transitioning, rather than a movement from one 
gender to another, could be a means of experimenting and exploring our many possibilities of 
self-actualization.  
 
 
241 ​Ibid. 
 
75 
Bibliography 
 
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth 
Edition. American Psychiatric Association. Arlington, VA. 2013. 
 
Arce, Santos. Interviewed by Lorenzo Van Ness. ​New York City Trans Oral History Project. 
Date of Interview July 14, 2017. http://oralhistory.nypl.org/interviews/santos-arce-nx3hjo#55:30. 
Accessed April 30, 2019. 
 
Benjamin, Harry. "The transatlantic commuter: An interview with Harry Benjamin (b. January 
12, 1885) on the occasion of his 100th birthday." By Erwin J. Haeberle. Archiv für 
Sexualwissenschaft. Last modified 1985. https://web.archive.org/web/20041227133920/ 
http://www2.hu-berlin.de/sexology/GESUND/ARCHIV/TRANS_B5.HTM. Accessed December 
9, 2018.  
 
Benjamin, Harry. ​The Transsexual Phenomenon. ​The Julian Press. 1966. Available online at 
http://www.mut23.de/texte/Harry%20Benjamin%20-%20The%20Transsexual%20Phenomenon.
pdf Accessed April 30, 2019. 
 
Beemyn, Genny. “Transgender History in the United States,” ​Trans Bodies, Trans Selves: A 
Resource for the Transgender Community​. Oxford University Press. 
https://www.umass.edu/stonewall/sites/default/files/Infoforandabout/transpeople/genny_beemyn
_transgender_history_in_the_united_states.pdf. 2014.  
 
Benjamin, Harry. “I Want to Change My Sex!,” ​Sexology: Modern Guide to Sex Knowledge​. 
Gernsback. December 1963.  
 
Cavanaugh, Timothy, Hopwood, Ruben, and Lambert, Cei. “Informed Consent in the Medical 
Care of Transgender and Gender-Nonconforming Patients,”  ​American Medical Association 
Journal of Ethics, Vol. 18, no​. 11, 1147-1155. 
https://journalofethics.ama-assn.org/article/informed-consent-medical-care-transgender-and-gend
er-nonconforming-patients/2016-11. Nov. 2016. 
 
Collins, Katherine. "Silent and Transfixed in the Transsexual Factory,” ​Transsexual News 
Telegraph​, Spring 1996.  
 
Conrad, Peter. “Medicalization and Social Control,” ​Annual Review of Sociology, Vol. 18, 
209-232. Annual Reviews. 1992. https://www.jstor.org/stable/2083452.  
 
Correspondence from Stanley Biber to Lou Sullivan, Feb 3, 1986. 
https://www.digitaltransgenderarchive.net/files/sj139204g. Accessed April 29, 2019. 
 
Day, Meagan.“How one of America’s best medical schools started a secret transgender surgery 
clinic.” ​Timeline​. Published Nov. 14, 2016. 
https://timeline.com/americas-first-transgender-clinic-b56928e20f5f. Accessed April 27, 2019. 
 
76 
 
Decision No. 2576; NCD 140.3; Transsexual Surgery. Department of Health and Human 
Services Departmental Appeals Board, Appellate Division. May 30, 2014. 
https://www.hhs.gov/sites/default/files/static/dab/decisions/board-decisions/2014/dab2576.pdf. 
Accessed April 30, 2019. 
 
 
Denny, Dallas. ​Identity Management in Transsexualism: A Practical Guide to Managing Identity 
on Paper​. Creative Design Services. 1994.  
 
Doroshow, Ceyenne. Interviewed by Cyd Nova, New York City Trans Oral History Project. 
Interview Date February 19, 2017. 
http://oralhistory.nypl.org/interviews/cayenne-doroshow-ejpsvu. Accessed April 30, 2019. 
 
 
Drescher, Jack. “Queer diagnoses revisited: The past and future of homosexuality and gender 
diagnoses in the DSM and ICD” in ​International Review of Psychiatry, Vol. 27 Issue 5​, 386-395. 
Taylor & Francis. October 2015. 
 
Deutsch, Madeline B. “Use of the Informed Consent Model in the Provision of Cross-Sex 
Hormone Therapy: A Survey of the Practices of Selected Clinics,”  ​International Journal of 
Transgenderism, Volume 13​, pp. 140-146. Routledge. 2011. 
DOI:10.1080/15532739.2011.675233. 
 
Elizabeth, Sr. Mary. ​Legal Aspects of Transsexualism​. International Foundation for Gender 
Education. 1990. 
 
Elkins, Richard. “Science, Politics, and Clinical Intervention: Harry Benjamin, Transsexualism 
and the Problem of Heteronormativity,” ​Sexualities​ ​Vol. 8, no. 3,​ pp. 306-328. 
 
Foucault, Michel. “Right of Death and Power over Life,” ​The History of Sexuality, Volume I​. 
Random House. 1978. Available online through 
http://home.ku.edu.tr/~mbaker/CSHS503/FoucaultHistorySex.pdf. 
 
Franklin, Michael David. “Calculating Risk History of Medicine, Transgender Oral History, and 
the Institutional Review Board,” ​Queer Twin Cities​. Twin Cities GLBT History Project. 
University of Minnesota Press. 2010. 
 
Gill-Peterson, Julian. ​Histories of the Transgender Child​. University of Minnesota Press. 2018. 
 
Glenza, Jessica. “Sky-high prices of everything make US healthcare the world’s most 
expensive,” ​The Guardian​. Published March 13, 2018. 
https://www.theguardian.com/us-news/2018/mar/13/us-healthcare-costs-causes-drug-prices-salar
ies. Accessed March 25, 2019.  
 
 
77 
Goldhill, David. “Who Defines ‘Medical Necessity’?” ​The Atlantic​. Published January 8, 2014. 
https://www.theatlantic.com/health/archive/2014/01/who-defines-medical-necessity/282500/. 
Accessed April 30, 2019. 
 
Griffin-Gracy, Miss Major. Interviewed by AJ Lewis, ​New York City Trans Oral History 
Project​. Date of Interview December 16, 2017. Interview Transcript #054. 
https://s3.amazonaws.com/oral-history/transcripts/NYC+TOHP+Transcript+054+Miss+Major+
Griffin-Gracy.pdf. Accessed April 30, 2019. 
 
Guffey, S.J. “Colorado town is sex-change world capital,” ​New Orleans Times-Picayune​. 
Published Jan 27, 1985. Transas City. 
http://transascity.org/files/news/1985_01_27_New_Orleans_Times-Picayune_B2. Accessed 
April 29, 2019. 
 
Holle, Dana. “Health is Health: Section 1557 of the Affordable Care Act and Transgender 
Healthcare Rights in Wisconsin and the United States,” ​Wisconsin Journal of Law, Gender & 
Society, Vol. 32, no. 2​, 239-259. 2017. 
 
Horton, Mary Ann.​ Cost of Transgender Health Benefits, Out & Equal Workplace Summit​. 
September 2008. http://www.tgender.net/taw/thbcost.html#thbcost.​ ​Accessed March 31, 2019. 
 
Israel, Gianna E., Tarver, Donald E., and Shaffer, Joy Diane. ​Transgender Care: Recom 
Guidelines, Practical Info. ​Temple University Press. http://www.jstor.org/stable/j.ctt1bw1hmt. 
1977. 
 
James, S. E., Herman, J. L., Rankin, S., Keisling, M., Mottet, L., & Anafi, M. ​The Report of the 
2015 U.S. Transgender Survey.​ Washington, DC: ​National Center for Transgender Equality. 
2016 
 
Jorgensen, Christine. ​Christine Jorgensen, A Personal Autobiography​. Bantam Books. 1967. 
 
Keith, Katie. “More Courts Rule On Section 1557 As HHS Reconsiders Regulation,” ​Health 
Affairs​. https://www.healthaffairs.org/do/10.1377/hblog20181002.142178/full/. Published 
October 2, 2018. Accessed March 26, 2019. 
 
Landman, Keren. “Fresh Challenges To State Exclusions On Transgender Health Coverage,” 
NPR​. Published March 2, 2019. 
https://www.npr.org/sections/health-shots/2019/03/12/701510605/fresh-challenges-to-state-exclu
sions-on-transgender-health-coverage. Accessed April 30, 2019. 
 
 
 
Major, Miss. interviewed by Susan Stryker. GLBT Historical Society. Interview Date January 
29, 1998.http://docs.glbthistory.org/oh/Major1-29-1988_web.pdf. Accessed April 25, 2019. 
 
 
78 
Marshall, Sarah Alexandra, Allison, Mary Kathryn, Stewart, Mary Kathryn, Thompson, Noel D. 
and Archie, Dani S. “Highest Priority Health and Health Care Concerns of Transgender and 
Nonbinary Individuals in a Southern State,” ​Transgender Health, Vol. 3.1​.Mary Ann Leibert, 
Inc. 2018.  
 
McQueen, Paddy. "The Role of Regret in Medical Decision-making,” ​Ethical Theory and Moral 
Practice, Vol. 20, no. 5.​ 1051-1065. https://doi.org/10.1007/s10677-017-9844-8. Nov 2017. 
 
Medical Policy Bulletin on Gender Reassignment Surgery, Number 0615. Aetna. Last updated 
January 11, 2019. http://www.aetna.com/cpb/medical/data/600_699/0615.html​. ​Accessed April 
30, 2019. 
 
Meyer, John K., and Reter, Donna J. “Sex Reassignment Follow-up,” ​Archives of General 
Psychiatry. 36, no. 9.​ 1010–1015. https://doi.org/10.1001/archpsyc.1979.01780090096010. 
1979.  
 
Meyerowitz, Joanne. ​How Sex Changed: A History of Transsexuality in the United States. 
Harvard University Press. 2002. 
 
Mission and Vision​, World Professional Association for Transgender Health. 
https://www.wpath.org/about/mission-and-vision. Accessed April 30, 2019. 
 
N.,  Ilhan. Interviewed by Tyler M. Date of Interview August 25, 2018. ​New York City Trans 
Oral History Project​. http://oralhistory.nypl.org/interviews/ilan-n-ku0e9m. Accessed April 30, 
2019. 
 
Peck, B. Mitchell and Conner, Sonya. “Talking with Me or Talking at Me? The Impact of Status 
Characteristics on Doctor-Patient Interaction” ​Sociological Perspectives, Vol. 54, No. 4 ​(Fall 
2011), 547-567. SAGE. Fall 2011. https://www.jstor.org/stable/10.1525/sop.2011.54.4.547. 552. 
 
Paine, Emily Allen. “Embodied Disruption: ‘Sorting Out’ gender and nonconformity in the 
doctor’s office,” ​Social Science and Medicine, Volume 221​, 352-358. Elsevier. 2018. 
 
Patel, Geeta. “Imagining risk, care and security: Insurance and fantasy,” ​Anthropological Theory, 
Vol. 7, no. 1​, 99-118. Sage. https://journals.sagepub.com/doi/pdf/10.1177/1463499607074297. 
2007. 
 
Pierce, Wendy. "An Interview with Dr. Stanley H. Biber,” ​Twenty Minutes: Anniversary Issue​, 
5-7. The XX Club. October 1989. Digital Transgender Archive. 
https://www.digitaltransgenderarchive.net/files/d791sg26z. April 29, 2019. 
 
Preciado, Paul B. ​Testo Junkie: Sex, Drugs, and Biopolitics in the Pharmacopornographic Era​. 
Feminist Press. 2013. 
 
 
79 
Schaefer, Leah Cahan, and Wheeler, Connie Christine.  "Harry Benjamin's first ten cases 
(1938-1953): A clinical historical note." ​Archives of Sexual Behavior Vol. 24, no. 1​, 73-93. 
March 1995. https://doi.org/10.1007/BF01541990. 
 
Schulz, Sarah L. “The Informed Consent Model of Transgender Care: An Alternative to the 
Diagnosis of Gender Dysphoria,” ​Journal of Humanistic Psychology, Vol. 58, Issue 1​, 72-92. 
Sage. 2017. DOI: 101177/0022167817745217. 
 
Shuster, Stef M. “Performing informed consent in transgender medicine,” ​Social Science & 
Medicine Vol. 226​, 190-197. 2019​. 
 
Skidmore, Emily. “‘Constructing the ‘Good Transsexual’: Christine Jorgensen, Whiteness, and 
Heteronormativity in the Mid-Twentieth-Century Press,” ​Feminist Studies, Vol. 37, No. 2, Race 
and Transgender Studies​, 270-300. Feminist Studies, Inc., 2011. 
 
Skinner, Daniel. “Medical Necessity under the Patient Protection and Affordable Care Act” in 
Public Administration Review, Vol. 73, The Health Care-Crucible Post-Reform: Challenges for 
Public Administration​, s49-s59. Wiley. September/October 2013. 
 
Smith, S. E. “Does Informed Consent Mean ‘Hormones on Demand’ for Trans People? Not So 
Much.” ​Rewire​ ​News.​ Published Jul 10, 2018. 
https://rewire.news/article/2018/07/10/informed-consent-mean-hormones-demand-trans-people-n
ot-much/.  Accessed April 16, 2019. 
 
Snorton, C. Riley. ​Black On Both Sides: A Racial History of Trans Identity​. University of 
Minnesota Press, 2017. Kindle Cloud Edition. 
 
Spade, Dean. “Medicaid Policy & Gender-Confirming Healthcare for Trans People: An 
Interview with Advocates,” ​Seattle Journal for Social Justice: Transgender Issues and the Law, 
Vol. 8, no. 2​, 497-514. 2010. 
 
Spade, Dean. ​Normal Life: Administrative Violence, Critical Trans Politics, and the Limits of 
Law​. South End Press. 2011.  
 
Spade, Dean. “Resisting Medicine, Re/modeling Gender,” ​Berkeley Women’s Law Journal, Vol. 
15​, 15-27. http://www.deanspade.net/wp-content/uploads/2010/07/resisting.pdf. 2003. 
 
Standards of Care​, Version 3. Harry Benjamin International Gender Dysphoria Association, 
1981. 
 
Standards of Care​, Version 7. World Professional Association for Transgender Health. Published 
2011. https://www.wpath.org/publications/soc. Accessed April 30, 2019. 
 
Stone, Sandy. ​The Empire Strikes Back: A Posttranssexual Manifesto. ​Published 1987. 
https://sandystone.com/empire-strikes-back.pdf. Accessed April 30, 2019. 
 
80 
 
Stryker, Susan. ​Transgender History: The Roots of Today’s Revolution.​ Seal Press. 2017 
Edition.Susan Stryker. ​Transgender History: The Roots of Today’s Revolution.​ Seal Press. 2017 
Edition. 
 
 
Whitehead, Jaye Cee, Thomas, Jennifer, Forkner, Bradley, and LaMonica, Dana. “Reluctant 
gatekeepers: ‘Trans-positive’ practitioners and the social construction of sex and gender,” 
Journal of Gender Studies, Vol. 21, no. 4, ​387-400. December 2012. 
 
Witkin, Rachel. “Hopkins Hospital: a history of sex reassignment.” The Johns Hopkins 
News-Letter. Published May 1, 2014. 
https://www.jhunewsletter.com/article/2014/05/hopkins-hospital-a-history-of-sex-reassignment-7
6004/. Accessed April 15, 2019.  
 
 
Urquhart, Evan. "Gatekeepers vs. Informed Consent: Who Decides When a Trans Person Can 
Medically Transition?" ​Slate​. Published March 11, 2016. 
https://slate.com/human-interest/2016/03/transgender-patients-and-informed-consent-who-decide
s-when-transition-treatment-is-appropriate.html. Accessed April 28, 2018. 
 
 
 
 
 
 
 
 
 
